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ABSTRACT
Phenotypic and genotypic characterization of lumbosacral stenosis in
Labrador retrievers
Meenakshi Mukherjee

Lumbosacral stenosis (LS) is a structural narrowing of the spinal canal in the canine
lumbosacral spine. Large-sized working and sporting dog breeds such as Labrador
retrievers are predisposed for reasons that are incompletely understood. The narrowing
of spinal canal observed in LS can cause compression of underlying meningeal, neural
and vascular tissues, which in turn can lead to clinical symptoms like lower back pain,
incontinence and in severe cases loss of function in the lower limbs. The standard
criteria for clinical diagnosis of this condition include a painful reaction to palpation of
lumbosacral spine region, inability or unwillingness to raise the tail and/or reluctance to
perform certain tasks that involve either the stretching of or stress on the lumbosacral
joint.

However, working and sporting breed dogs are bred to be highly stoic,

cooperative, driven, and task focused. These behavioral traits make clinical detection of
LS difficult in the early stages. Dogs with LS may continue to work, develop
compensatory gaits, and experience repeated LS injury. By the time a diagnosis of LS
is confirmed, oftentimes it is too late for successful therapeutic intervention and the only
course of action left for improving the dog’s quality of life is either retirement from active
duty, or in severe cases euthanasia. Therefore early diagnosis is essential for
maximizing the quality of life, and minimizing the likelihood of early retirement in working
dogs. Lumbosacral stenosis is usually considered to be a condition associated with
degenerative changes observed with normal aging, however presence of the disease in
young and middle aged working dogs has also been reported. This leads to the
probable theory that some dogs in large breeds like Labrador retrievers might be
genetically pre-disposed to LS.

ii

Radiographic screening is common practice for agencies that purchase, train, and use
working dogs. Dogs with morphologic traits such as canine hip dysplasia, canine elbow
dysplasia, and transitional lumbosacral vertebrae are commonly rejected. However
radiographs are insensitive for detecting LS. Advanced imaging methods such as
computed tomography (CT) and magnetic resonance imaging (MRI) and the current
standard diagnostic tests for detection of LS. These modalities are considered to be
complimentary, with each offering different strengths for visualization of bony and soft
tissue structures.

For working dogs, computed tomography offers advantages of

greater availability and the faster scanning times that allow the use of reversible
sedation. Qualitative CT phenotyping is a standard method for clinical diagnosis of LS
in dogs. However, for research purposes, a method for quantitative phenotyping of LS
would also be beneficial. There is a lack of published evidence for a consensus on any
such quantitative CT phenotypic traits in humans or dogs. In the first study, we
developed one such quantitative trait using CT imaging in a sample of 25 Labrador
retrievers – fat area ratio or FAR (ratio of the vertebral canal fat area content in a
transverse slice to the vertebral body area in the same transverse slice). This
measurement was found to have good agreement with the standard qualitative
assessment of LS (as made by a certified veterinary radiologist); and we propose that
FAR can be used to quantify LS especially in a research capacity.
Lumbar spinal stenosis (LSS) is a human condition that is often considered to be
orthologous to canine LS. Genetic studies in humans have shown promise in
identification of possible genetic factors that might be associated with LSS. The
predominant genetic approach for research in canine LS has been pedigree analysis
especially in the German shepherds; but no genetic association studies have been
reported in any breed.

The second study of the project was an attempt at the

investigation into the genetic characteristics of LS in Labrador retrievers. To do so we
analyzed the exome of 8 young Labrador retrievers – 4 positive for LS and 4 negative
for LS, from a pool of 40 Labrador retrievers in the US military working dog (MWD)
program. The FAR measurement (from previous retrospective study in 25 dogs) was
iii

used for quantitative phenotyping of the 40 dogs (as well as qualitative CT
phenotyping); followed by the selection of 8 dogs best representing the extremes of the
phenotype – LS affected and LS unaffected. We were able to identify 3 genes – TTR
(Transthyretin), FOLR2 (Folate Receptor 2) and USP9X (Ubiquitin Specific Peptidase 9,
X-linked) – that could possibly be associated with canine LS. However, follow-up
analysis is necessary to determine the true nature of the relationship between these
genes and LS in Labrador retrievers. These 3 genes could potentially be new
“candidate genes” for canine LS – not just in Labrador retrievers but also in other
affected breeds. Further studies are also needed to investigate the role of these
candidate genes in human LSS.

The inability of LS in getting detected by simple

radiographs is a major disadvantage for the agencies that procure, train and employ
working dogs like the military and transportation safety authority. This necessitates the
identification of genetic marker/s of LS that could then possibly be developed into
simple diagnostic tests. And if certain breeds are indeed genetically predisposed, these
diagnostic tests could perhaps even become standard screening protocol during the
acquisition of these dogs. Labrador retrievers are loyal, kind, and intelligent breed of
dogs; with greatly versatile applications beneficial to humans. Even though other breeds
are used as working dogs around the world, Labrador retrievers cannot be easily
replaced and the demand for this breed has been steadily increasing over the past
decade. A possible genetic test that can identify genetic predisposition to LS in young
Labrador retrievers that might become working dogs can significantly improve the
procurement process. And if reasons behind early occurrence of LS were premature
degenerative changes instead, early detection would mean preventative conditioning
training protocols and better therapeutic treatments. However, it is important to note
that LS is not restricted to working dogs (young and old) alone, the disease also
appears in non-working dogs (more commonly in older dogs). But, early detection of LS
would improve the quality of life of Labrador retrievers – both working and non-working
that might be affected by LS. It would also be beneficial for the agencies that employ
and have financial stakes in these dogs.

iv

DEDICATION
This document marks the completion of a nearly four-and-a-half-year long project
towards a doctoral degree in genetics. None of this would have been possible without
the love and support from the two most important people in my life – my parents. I
would like to thank them both from the bottom of my heart for all the sacrifices that they
have made over the years, making it possible for me to be where I am today. I share the
honor of this degree with both of them. I owe who I am today – as a person and as an
academic – to the values that they instilled in me. I would also like to acknowledge all
the friends I have made throughout my life – you all have shown me love, loyalty and
support. I am a better individual today for having known all of you and I am extremely
grateful that you all chose me to be your friend. And last but not the least (even though
she will be unable to read this), I would like to thank my best friend and loving loyal
companion Maggie, for always being present with unconditional love and support.

v

ACKNOWLEDGEMENT
I would first like to thank all my committee members for their guidance throughout this
project – both with experimental design and implementation of the study. I would like to
thank staff members at the Veterinary Teaching Hospital in the Virginia-Maryland
College of Veterinary Medicine, Ryan Hospital in the University of Pennsylvania, and
the Holland Military Dog Hospital in the Lackland Air Force Base for assistance in
acquiring data for the dogs used in the study. I would also like to acknowledge the WVU
Genomics Core Facility at West Virginia University for help with genetic and
bioinformatic analyses. I am also grateful to Dr. Holásková for her help with the
statistical analyses in the project. I also extend my gratitude to the staff members at the
Animal and Nutritional Sciences Department of West Virginia University for their help
with all the administrative work. I am also grateful to Clemson University, Dr. Leigh Ann
Clark and the members of the canine genetics laboratory for technical guidance. I would
like to thank Dr. Jeryl Jones for believing in my abilities right at the onset and giving me
this opportunity to pursue my doctoral degree, but also guiding and helping me
throughout this entire journey. And last but not the least I would like to thank Dr. Jianbo
Yao for taking me in as a graduate student for the last year and allowing me to finish my
work in West Virginia University, and agreeing to be my co-major advisor. This project
was funded by the following agencies: West Virginia Agricultural and Forestry
Experiment Station USDA Hatch Act Formula Grant, Davis Michael Endowment for PreVeterinary Sciences; and the US Army Research Office.

vi

TABLE OF CONTENTS
Abstract

ii

Dedication

v

Acknowledgments

vi

Table of Contents

vii

List of Figures

viii

List of Tables

ix

List of Appendices

x

List of Symbols, Abbreviations and Nomenclature

xi

Chapter I. Introduction

1

Chapter II. Review of literature

5

Chapter III. Phenotypic characterization of lumbosacral stenosis in Labrador
retrievers
Chapter IV. Genetic characterization of lumbosacral stenosis in Labrador
retrievers
Chapter V. Overall Summary and Conclusions

26

Chapter VI. Recommendations

98

49
94

Bibliography

101

Appendices

123

Curriculum Vitae

142

vii

LIST OF FIGURES
Figure III.1. Positioning of a dog for acquiring CT scan of the lumbosacral

37

spine.
Figure III.2. Lateral CT image depicting the six measured locations of the

38

canine lumbosacral spine
Figure III.3. Representative screenshots illustrating the methodology for the

39

quantitative measurements
Figure III.4. Mean canal area ratio comparisons between LS-positive and LS-

40

negative dogs
Figure III.5. Mean fat area ratio comparisons between LS-positive and LS-

41

negative dogs
Figure III.6. Logistic regression between quantitative measurements and

42

qualitative assessment of lumbosacral stenosis
Figure III.7. Predicted probabilities for being LS-positive at each of the six

44

vertebral locations.
Figure IV.1. Consequences of 229 variants analyzed by Ensembl Variant Effect

72

Predictor
Figure IV.2. Percentage breakdown of variants with coding regions based on

73

type of mutation
Figure A.1. Mean canal area ratios (CARs) in study 1

121

Figure A.2. Mean canal area ratios (CARs) in study 2

122

Figure A.3. Mean fat area ratios (FARs) in study 1

123

Figure A.4. Mean fat area ratios (FARs) in study 2

124

Figure A.5. Mean canal areas (CAs) in study 1

125

Figure A.6. Mean canal areas (CAs) in study 2

126

Figure A.7. Mean fat areas (FAs) in study 1

127

Figure A.8. Mean fat areas (FAs) in study 2.

128

Figure A.9. Logistic regression of FAR v qualitative LS at L6Cr

130

Figure A.10. Logistic regression of age v qualitative LS at L6Cr

131

viii

LIST OF TABLES
Table II.1. Major causes of lumbar spinal stenosis in humans

25

Table III.1. Clinical data demography of the study samples

46

Table III.2. T-test p-values for canal area ratio and fat area ratio comparisons

47

between LS-positive and LS-negative dogs
Table III.3. Logistic regression p-values – quantitative measurements (CAR and

48

FAR) and qualitative CT assessment of stenosis
Table IV.1. Clinical data demography of the study samples

74

Table IV.2.A. Maximum and minimum fat area ratio values for 8 vertebral

75

locations among the 8 dogs selected to represent the extremes of the
phenotype – 1st round of selection (samples lost)
Table IV.2.B. Maximum and minimum fat area ratio values for 8 vertebral

76

locations among the 8 dogs selected to represent extremes of the phenotype –
2nd round of selection (whole exome sequenced samples)
Table IV.3. Demographic data of the 8 dogs selected for exome sequencing

77

Table IV.4. List of single nucleotide variants present within the canine exome

78

and the genes that the exons correspond to as detected by manual curating
Table IV.5. List of canine genes with exonic single nucleotide variants and their

81

percentage homology with human and mouse orthologues
Table IV.6. Variants with moderate impact as detected by Ensembl’s Variant

83

Effect Predictor (VEP)
Table IV.7. Biological significance and function of the 33 genes with detected

84

exonic variants
Table IV.8. Human LSS candidate genes and their location in the canine
genome

ix

93

LIST OF APPENDICES
Appendix I: Protocol used for DNA extraction from FTA cards

123

Appendix II: Description of an unexpected qualitative phenotypic trait observed

126

in this sample of Labrador retrievers, i.e. “a reverse trapezoid vertebral canal”.
Appendix III: Logistic regression analysis of the association between FAR and

136

qualitative LS status in the 40 dogs recruited for the second study (chapter IV)
Appendix IV: Proposed explanations for clinical low back pain observed in

139

dogs from both studies.
Appendix V: Analysis of covariance and multivariate logistic regression tests
for effects of covariates on comparisons between FAR and LS status in dogs
from both studies.

x

141

LIST OF SYMBOLS, ABBREVIATIONS AND NOMENCLATURE
LSS – Lumbar Spinal Stenosis
LS – Lumbosacral Stenosis
CT – Computed Tomography
MRI – Magnetic Resonance Imaging
Cr – Cranial end of vertebrae
Cd – Caudal end of vertebrae
L4 – 4th lumbar vertebrae
L5 – 5th lumbar vertebrae
L6 – 6th lumbar vertebrae
L7 – 7th lumbar vertebrae
S1 – 1st sacral vertebrae
LBP – Low Back Pain
CAR – Canal area ratio (transverse vertebral canal area / transverse vertebral body area)
FAR – Fat area ratio (transverse vertebral fat content area / transverse vertebral body area)
DNA – Deoxyribonucleic acid
SSA – Systemic Senile Amyloidosis
JJ – Jeryl C. Jones
MM – Meenakshi Mukherjee
IH – Ida Holásková

xi

CHAPTER I. INTRODUCTION
Working dogs are high-performance athletes and vital members of teams that support
public service, national security and military missions in the U.S. and around the world
1

. The job titles of working dogs are varied and include, but are not limited to: guide

dogs (for the disabled like the blind and the deaf); service dogs (for individuals with
medical conditions that range from epilepsy to diabetes); assistance and therapy dogs
(for individuals with physical disabilities and post-traumatic stress disorder as seen in
war veterans); detection dogs (explosives, arson accelerants, illegal drugs, agricultural
pathogens, pirated DVDs and other contraband, for the Transportation Security
Administration, the police, and the military); and search and rescue dogs (natural or
man-made disasters). The list of ways in which dogs are trained to perform currently
(and could potentially be trained to in the future) are both varied and numerous. German
shepherds, Labrador retrievers, and Belgian Malinois are the most commonly used
breeds
3

2

and; since 9/11, the demand for working dogs has only increased dramatically

.

One such in-demand population of working dogs is the military working dog (MWD).
Military forces worldwide recognize MWDs as “force multipliers”. An American Forces
Press Service release (October, 2015) estimated the US military to have around 2,300
MWDs

(http://usmilitary.about.com/od/jointservices/a/militarydogs.htm).

The

dogs

represent all branches of the military, and together with their handlers they are deployed
worldwide to serve American interests. According to a 2011 US Government Pentagon
memo, typical purchasing and training costs for a high quality military working dog can
range anywhere from $20,000 to $40,000 (depending on the nature of their
assignments, and whether or not the dog is trained for multiple types of tasks)
(http://www.nytimes.com/2011/05/12/world/middleeast/12dog.html?_r&_r=0). Once they
are trained, the service lifetime of a typical MWD is expected to average about 10–12
years (http://todaysmilitary.com/videos/a-military-working-dog-handler). However this
time is often cut short significantly by degenerative spinal disease, overuse injuries, and
1

trauma 2. Premature loss of active duty capability in a trained MWD causes not only a
major financial loss to the US Military, but also a functional loss for the productivity of
the team that depends on the particular dog. Team readiness remains reduced until
they can purchase and train a new dog. As the worldwide competition for high quality
dogs increases; so does the cost of breeding, raising and subsequent training of the
dogs, as a result of which, the availability of new dogs also decreases. Therefore,
ideally teams need to have dogs that can maintain functionality for as long as possible.
Lumbosacral stenosis (LS) is the most common pathological condition affecting the
canine lumbosacral spine

4 5 6

. Lumbosacral stenosis is defined as an abnormal

narrowing of the lumbosacral canal, vertebral canal, and/or the intervertebral foramina
between the L5-S3 vertebral segments leads to the compression of the underlying
neural and vascular tissues 7 8. This structural “narrowing” can lead to clinical conditions
like cauda equina syndrome (CES). Degenerative LS is the most commonly reported
etiology that is believed to be associated with aging; similar to the orthologous human
condition known as lumbar spinal stenosis (LSS). However, some studies suggest LS
might have a genetic predisposition that can manifest itself at an early age

9 10 11

. This

predisposition has been predominantly accounted for by the congenital anomaly of
lumbosacral transitional vertebra (LTV) – an abnormally formed vertebra usually
between the last lumbar and first sacral vertebra

12 13

. The presence of LTV often leads

to abnormally narrow spinal canal (lumbosacral stenosis); which in turn can lead to
clinical conditions like CES. Congenital version of LS is rare, but the causes can be
either developmental (achondroplasia related) or idiopathic (reasons unknown).
The larger sized breeds like German shepherds, Labrador retrievers and Golden
retrievers that are the popular choice for working dogs also happen to have a higher
than normal incidence of LS. Scientific research of canine LS has leaned heavily on the
German shepherds breed, both due to high number of reported cases as well as their
popularity as working dogs. However in recent years the popularity of the Labrador
retrievers breed has been increasing steadily in the working dog community especially
2

due to their excellent scent detection skills, high drive, eager-to-please attitude and
ease of trainability

14 3

. Labrador retrievers are also the most popular household pet

breed in the United States, and have been so for the past twenty-five years in a row

15

.

Unfortunately the very characteristics that make this breed such great working dogs;
also make it difficult to detect LS. Working Labrador retrievers are excellent at masking
their pain and discomfort to continue pleasing their people/handlers/owners. The
degenerative/progressive nature of the disease can be extremely harmful if
detection/management is delayed. Currently CT/MRI imaging methods are the only way
of detecting the structural abnormality of stenosis or “narrowing”. However, unless a dog
presents with some clinical signs of pain or discomfort, expensive imaging studies are
not performed in “suspicion” of an underlying condition like lumbosacral stenosis; and
the condition can go undetected longer often exacerbating the condition. Therapeutic
interventions are more effective in young dogs with mild stage clinical conditions, with
relatively successful return to active life, thus the need for early detection

16

. The

procurement, training and ultimately the deployment of the working dogs to their theater
of duty is an extensive process that involves significant investment of time, money and
other valuable resources. An improved understanding of the genetic mechanisms
underlying LS would be highly beneficial – not only for better therapeutics but also for
better diagnostics.
Findings from canine LS studies in Labrador retrievers could also be applicable to other
dog breeds (and possibly humans too due to the pathophysiological similarity between
canine LS and human LSS). Lumbar spinal stenosis is defined as “any type of
narrowing of the spinal canal, nerve root canals or intervertebral foramina” that leads to
neurogenic claudication

17

. Degenerative LSS is the most commonly reported type of

human LSS affecting individuals older than 65

18 19

. However aging is not the sole

contributing factor for this structural abnormality, even though rare LSS has also been
observed in younger individuals. The most common type of congenital LSS is usually
associated with dwarfism related genetic disorders (supporting the theory that LSS is a
genetic disorder, albeit a complex one). Some studies have tried to identify and
3

understand the underlying genetic mechanism of LSS. They have been able to identify
some genetic polymorphisms that appear to be associated with the presentation of LSS
20 21

. In the United States alone, there is an estimated 400,000 individuals affected with

LSS

22

. Decompressive surgery to correct LSS has become the most common spinal

surgical procedure in recent times

23

. Similar to the canine version, LSS is not life

threatening but it does significantly diminish the quality of life due to substantial
disability, limiting the ability to perform routine daily life activities. Currently there is no
cure for LSS in humans or LS in dogs, only ways of managing the symptoms to improve
the quality of life

24 25 22

. The genetic similarities between the two species – human and

canine, could allow findings in one to benefit the other.

4

CHAPTER II. LITERATURE REVIEW
Lumbar Spinal Stenosis
Anatomy of the normal lumbar spine
The spinal canal is delineated by the vertebrae, discs and the posterior longitudinal
ligament anteriorly; pedicles, the ligamentum flavum and the neuro-foraminae laterally;
and laminae, facet joints and the ligamentum flavum posteriorly. The normal shape of
the human lumbar spinal canal can be circular, elliptical/oval or trefoil (rounded triangle)
26 27

. There is a gradual change from a more circular to a more triangular shape

(narrowing trend) as the spine transitions from thoracic to sacral region. The trefoil
shape of the spinal canal usually appears in the fifth lumbar vertebrae. The anteroposterior (AP) diameter of the lumbar spinal canal usually decreases from L1 to L3 and
increases from L3 to L5, so it is at its narrowest at the third lumbar vertebrae

28 29 30

.

There is a small increase in the transverse diameter from L1 to L3, after which (L3 to
L5) there is a simultaneous increase corresponding to the increase in AP diameter.
Cross-sectional areas decrease from L1 to L2, remains somewhat constant in L2 to L4,
followed by an increase at L5. The consistent increase in the cross-sectional area of the
lower spine from all angles seems to be present to accommodate the neural tissue of
the cauda equina. Cauda equina, which literally translates to “horse’s tail”, is the bundle
of all the spinal nerves and nerve roots that originate throughout the spine (2nd to 5th
lumbar, 1st to 5th sacral and the single coccygeal) but emerge only from the conus
medullaris (termination point of the spinal cord).

Etiology and pathogenesis
The amount of space available to the nervous tissue inside the spinal canal is decided
by a combination of two factors: morphogenesis and development of the spine during
gestation and the early developmental years; and the degenerative changes that occur
to the spine over the course of time. The lumbar vertebrae begin to form after the
seventh week of gestation when two chondrification centers, one in each vertebral arch,
5

begin to develop

31

. These arches then start to ossify and meet at the centrum – the

union being the first defining event to decide the dimensions of the neural canal (even
though the canal does not finish forming until several years after birth)

32

. Any kind of

error during this stage can result in a narrowed spinal canal, which can remain clinically
asymptomatic until other confounding factors give rise to a clinical condition. The
stenotic canal usually presents with a narrower inter-pediculate diameter
pedicles and lamina appear to be shorter and thicker

34

33

. Both the

. The facets also become

enlarged and bulbous, nearly coming in contact with the spinous processes. This
abnormal narrowing of the spinal canal, nerve root canals and/or intervertebral foramen
leading to compression of the inner neural tissue is defined as spinal stenosis 17.
Arnoldi classified lumbar spinal stenosis into three types based on anatomy – central
canal stenosis (bordered by vertebral bodies, discs, and articular processes); lateral
recess stenosis (sub-articular canal extending from the thecal sac to the pedicle); and
foraminal stenosis (intervertebral foramen or nerve root canal present under the pedicle)
17

. The causes that result in the different forms of stenosis are as follows: 1) central

canal stenosis from hypertrophy of the interlaminar portion of the ligamentum flavum, or
disc protrusion/herniation; 2) lateral recess stenosis from degeneration of the ligaments
and/or facets, disc herniations, posterolateral disc protrusion, or superior articular
process hypertrophy; and; 3) foraminal stenosis from bone “spur” formations
(osteophytes), facet joint hypertrophy (osteoarthrosis), or tissue hypertrophy due to
spondylolisthesis.
Arnoldi (1976) classified lumbar stenosis into three types based on etiology –
congenital, acquired, or a combination of both. First reported in children by Sarpyener
(1945) 35, the congenital form can be further divided into two categories – idiopathic and
achondroplastic. The idiopathic form is extremely rare and only a few cases have been
reported to date. The achondroplastic form is slightly more common and is associated
with dwarfism related disorders
cervical canal stenosis

37

36

. However, recent studies have reported congenital

and lumbar spinal stenosis
6

38

in adults younger than 51, with

39

cervical form being more common in younger individuals than the lumbar form

.

Verbiest (1954) was the first to observe acquired stenosis in adults. This form of
stenosis has proved to be the most prevalent type and is usually known to present itself
in individuals older than 65

18

. This delayed appearance of stenosis is believed to be

due to the association of spinal stenosis with aging. It may often take up to the fifth
decade of life for the degenerative effects of aging to accumulate and manifest itself
with initial clinical signs. Commonly observed degenerative changes associated with
LSS are disc degeneration, facet joint osteoarthritis, ligament hypertrophy, spondylosis,
spondylolisthesis, and/or osteophytes
surgical

41

or traumatic conditions

Paget’s disease

44

42

40

. Acquired stenosis can also be a result of

, like – diffuse idiopathic skeletal hyperostosis

, ankylosing spondylitis

diseases like acromegaly

48 49

45 46

, or rheumatoid arthritis

, hypoparathyroidism

X-linked hypophosphatemic osteomalacia

52

50

47

43

,

. Metabolic

, pseudohypoparathyroidism

51

, or

can also cause lumbar spinal stenosis.

Ciricillo and Weinstein (1993) have listed the known causes of spinal stenosis in their
review paper (Table II.1) 53.

Clinical presentation
The first ever mention of lumbar spinal stenosis related symptoms was in Greek
mythology – the God Hephaestus was achondroplastic, and after a trauma to the
narrow spinal canal developed a limp, which in turn led him to being mocked by the
Olympians

54

. Mythological references aside, the French physician Antoine Portal was

the first to correlate low back pain (LBP) with narrowing of the spinal canal

55

. However

until the 1950’s, the primary cause for LBP was believed to be solely disc-related

56

and

spinal stenosis as a cause for LBP went mostly uninvestigated. Dutch neurosurgeon
Hank Verbiest was the first to coin the term “spinal stenosis” in his landmark 1954
publication

57

. Even though LBP is the symptom most commonly associated with spinal

stenosis, it is not the defining symptom for diagnosis of the disorder – clinical symptoms
can be highly variable. The current standard clinical symptom for a confirmed diagnosis
of LSS is neurogenic claudication – described as the presence of weakness, tiredness,
burning pain, cramps, and/or discomfort in the legs on walking short distances that
7

usually go away on resting

58 59 17 60

. However, there exists a lack of consensus

regarding the true constitution of the clinical symptoms that arise due to LSS, making
diagnosis difficult

61

. However, there exists a lack of consensus regarding the true

constitution of the clinical symptoms that arise due to LSS, making diagnosis difficult 61.
The physiological explanation of the symptom of intermittent neurogenic claudication is
made up of the combination of two theories – neurogenic compression theory and
vascular compression theory

62 60 63

. The neurological dysfunction can be explained by

the neurogenic compression theory. As seen in animal models, if there is mechanical
stimulation after prolonged compression of neural tissue, an abnormal electrical
discharge happens that presents itself as pain. Compression of neural tissue actually
means decreased supply of cerebrospinal fluid and other nutritional substances to the
nervous tissue, which in turn causes edema, build-up of noxious substances and
fibrosis due to microvascular changes. The intermittent aspect of the functional
dysfunction can be explained by vascular compression theory. According to this theory,
the increased pressure inside the spinal canal is not only on the neural tissue but also
on the blood vessels that supply the neural tissue. When active or in motion, the
compressed blood supply is not sufficient for proper functioning of the neural tissue,
causing pain. When in rest, the canal widens, blood supply becomes sufficient enough
and the pain goes away. But both the theories cannot explain how some patients with
severe stenosis can still remain asymptomatic. Other symptoms include mechanical
low-back pain that worsens during activity, atypical non-radicular leg pain, pain in the
buttocks and on rare cases cauda equina syndrome

56 64

. Cauda equina syndrome may

include associated symptoms of urinary and bowel incontinence.
With regards to the localization of symptoms, the pain is bilateral and poorly localized in
central canal stenosis, while in lateral canal stenosis the pain is more localized to one or
few nerve roots

53

. Multi-level neural tissue compression has also been associated with

neurogenic claudication in cauda equina syndrome

65 62 60

. However, it should be noted

that the number of vertebral levels affected by stenosis has shown no direct correlation
8

with the severity of clinical symptoms displayed. Some studies suggest that males are
affected by LSS more than females

66 67 53

; however contradictory reports have also

been published where any one sex has not proved to be more affected by LSS than the
other 19.

Clinical diagnosis and diagnostic imaging
Congenital forms of stenosis, though rare, are easily diagnosable by radiographs 68. The
acquired form of stenosis is slightly more deceptive. Even though a chronic condition,
the symptoms of LSS can often develop insidiously with sudden onset. Clinical
examination can also be misleading, but once detected, like similar spinal disorders, a
thorough neurological examination is mandatory protocol 69. The non-specific symptoms
include limited lumbar extension, sensory deficit, muscle weakness, straight-leg raising,
and missing knee and ankle reflexes. The intermittent as well as the sometimesasymptomatic nature of the symptoms like neurogenic claudication can often lead to
delayed diagnosis. Thus, the only way to confirm a positive diagnosis of LSS is through
diagnostic imaging studies

70 71

. Each confirmed case of LSS by imaging can be further

graded as mild, moderate or severe; but this grading is subjective and can be another
cause of misdiagnosis.
The two most common diagnostic tests for LSS in human and LS in dogs are computed
tomography (CT) and magnetic resonance imaging (MRI). These methods are often
considered to be complementary to each other. The most striking difference between
the CT and MRI is that denser tissue appears brighter and whiter in CT, while denser
tissues appear darker and blacker in MRI. Computed tomography works on the principle
of electromagnetic energy attenuation – x-ray photons penetrate the body and based on
the density of the target tissue, some of the energy gets absorbed and the rest exits the
body slightly attenuated. The residual energy that escapes the body gets registered on
a photon detector which when developed, reflects the difference in tissue densities
depicted in shades of grey. MRI is also an emission-based technology that takes
advantage of the water content in living tissues. Protons present in water molecules
9

emit radiofrequency signals in the presence of opposing magnetic fields and start
resonating. This resonance is detected and recorded in the form of grey-scale images.
Computed tomography uses a hollow x-ray tube that rotates around a stationary patient
table, emitting x-rays that pass through and get captured as a series of x-ray projections
on detector films, producing cross-sectional anatomical images that distinguish between
tissues based on density differences

72 73

. Computed tomography can capture images

from multiple panes, and give a detailed and precise three-dimensional visual for the
bone and soft tissue structures inside the body (after multiplanar reconstruction)

74 75

.

The ability of CT lies to capture images in the trans-axial plane makes it the preferred
imaging method for the detection of LSS

76

. Computed tomography also allows

evaluation of the shape of the canal, and making accurate measurements of the bony
spinal canal dimensions directly from the images. Computed tomography has good
contrast resolution (differentiating between bony and soft tissue) and can directly view
the effects of disk pathology, facet hypertrophy, and thickened ligamentum flavum on
the cross-sectional area of the canal

77

. However, the soft tissue resolution of CT is not

as great as that of MRI – making it difficult to detect nerve root compression and other
soft tissue pathologies. It is possible to overcome this disadvantage of poor soft tissue
resolution by detecting changes in adjoining tissues (dural sac and epidural fat) for
diagnosis of LSS

78

. Therefore, CT is the considered to be an optimum imaging

technique for the overall diagnosis of LSS –balanced detection capability of changes in
both bony and soft tissue. Spinal canal area measurements made by CT often do not
agree with measurements made by MRI often in the same samples, theorized to be due
to the superior delineation of the ligamentum flavum by CT
also better at visualizing zygapophyseal joints

80

79

. Computed tomography is

and differentiating between hard

versus soft disc pathology 81.

Qualitative and quantitative computed tomography characteristics
The application of CT to spinal imaging began in the 1970s and has since then provided
great insights into the various factors that can lead to LSS (narrowing of the spinal canal
10

and compression of the emerging nerve root)

82 83 84 71

. McAfee and Ullrich (1982)

described the normal anatomy of the lumbar spine, using the 5th lumbar vertebra as an
example, as observed in 3 successive trans-axial CT images (increments of 1.5 mm):
First slice: nerve roots lie in an unresolved bunch within the lateral recesses of the
vertebra at the lower edge of the pedicles, and epidural fat remains distributed around
the thecal sac in a symmetrical manner. Second slice: nerve roots exit through the
upper portion of the neural foramina that lies immediately beneath the lower margin of
the pedicles, the ligamentum flavum appears as a V-shaped soft tissue behind the
thecal sac, the anterior extensions of which join the medial portions of the facet joint
capsules. Third slice: nerve roots become part of the paraspinal structures after its exit
from

the

neural

foramina

and

the

posterior

longitudinal

ligament

remains

indistinguishably adjacent to the annulus fibrosis.
A stenotic canal appears distinctly different from the normal canal in a CT image

70 83

.

Qualitative characteristics of LSS visible in CT images include: bulging discs,
osteophytes along the vertebral margin, spondylolisthesis, thickened pedicles, spinous
and transverse processes, thickened ligamentum flavum, facet joint capsule
hypertrophy and subluxation, and/or degeneration of the discs

71

. These bony and soft

tissue abnormalities can be both causes of LSS, as well as symptoms and side effects
of LSS. This in turn leads to difficulty in identification of the actual cause of stenosis in
an individual once the symptoms start progressing. Since the visible structural
abnormalities usually present themselves in combinations of each other, separating one
from the rest can be difficult 77 75 85.
Even though LSS is defined as “narrowing”, there are very few evidence-based reports
where the “stenotic” vertebral canal dimensions have been defined, or compared with
“normal” canal dimensions
first to be proposed

87

86

. Radiological measurements for a stenotic canal were the

but their accuracy was questionable due to two reasons: (i) they

were static measurements and did not account for the dynamic nature of the condition;
and, (ii) they were estimates and not exact values. Computed tomography is the better
11

choice as it allows for exact measurements of the spinal canal while also taking into
account that LSS is a dynamic and multi-level condition

62 65

. This is possible because

CT also allows for images to be collected from symmetric axial sections perpendicular
to the anterior bony wall of the vertebral canal
described

their

quantitative

criteria

for

88 89

. McAfee and Ullrich (1982)

diagnosing

LSS

using

3

numerical

measurements: (1) antero-posterior (AP) diameter; (2) inter-pediculate distance; and (3)
cross-sectional area; and a canal was assigned LSS positive if either the anteroposterior diameter was less than 11.5 mm, and/or inter-pediculate distance was less
than 16 mm, and/or cross-sectional area was less than 1.45 cm2 75. Schonstrom (1985)
defined the threshold for a ”stenotic” canal as a cross-sectional area of 0.85 cm2 83; and
Zheng (2006) assigned a cross-sectional area threshold value of 1.4 cm2

90

. Verbiest

(1954) defined a canal as “stenotic” when the sagittal diameter was less than 10 mm. Of
the three measurements described by Ullrich (1982): AP diameter, inter-pediculate
distance and cross-sectional area – the cross-sectional area measurement is
considered to be the most sensitive for diagnosis of central canal stenosis since it
integrates the entire bony ring that forms the canal and is more likely to detect
asymmetrical canal narrowing or lateral canal narrowing 77 85 83 91 92.

Genetic characteristics
The congenital form of stenosis is typically associated with achondroplastic disorders,
which are genetic disorders by nature

36 93

. So it has long been suspected that other

types of LSS might also be influenced by genetic factors. Some early familial studies of
LSS in siblings have also pointed towards a genetic connection 94 95 96.
Ossification of posterior longitudinal ligament (OPLL) is a pathology that can often lead
to LSS and has a higher than normal incidence in the Japanese population

97

. This

genetic predisposition in a geographically distinct population also supports the theory
that LSS is influenced by genetic factors. Both Postacchini (1985) and Yoshida (1992)
have discussed the importance of collagen fibers in the disease process of LSS

98 99

.

Maeda et.al (2001) identified a linkage between OPLL and a region of chromosome 6p
12

that also contains the gene COL11A2

100

. Lumbar disc disease (LDD) is another

pathology that is believed to be a leading cause of LSS. Tryptophan alleles in COL9A2
(Trp 2)

101

and COL9A3 (Trp 3)

102

have shown an association with LDD in the Finnish

population. A study done in mice to study age-related spine degeneration, identified a
heterozygous mutation that causes haplo-insufficiency of the aggrecan gene (AGC1)
and results in intervertebral disc herniation and degeneration

103

. This finding in mice

was later repeated in humans along with identification of an association between a
VNTR in AGC1 and LDD in humans

104

. Lumbar disc degeneration has also been

associated with polymorphisms in vitamin D receptor gene (VDR)
metalloproteinase-3 gene MMP-3

107

105 106 81

and matrix

. All these polymorphisms found in OPLL and LDD

(diseases closely related and presenting simultaneously with LSS), support the theory
that LSS could also be influenced by genetic factors 20.
Noponen-Hietala et.al were the first to investigate candidate genes of LSS based on
genes identified in related diseases. The study subjects comprised of 29 probands (LSS
positive) and 56 controls (LSS negative) from the Finnish population. The phenotype
was established using both CT and MRI. The following 9 candidate genes were
selected – COL1A1, COL1A2, COL2A1, COL9A1, COL9A2, COL9A3, COL11A1,
COL11A2 and AGC1. The study also included 2 SNPs in VDR gene and one SNP in
MMP-3 gene promoter. The study was able to identify two variants in COL9A2 gene –
(i) a>c in IVS26-2, and (ii) Gln326 >Trp (Trp2 allele). An Arg103>Trp (Trp3 allele) change
in COL9A3 was also found. The previously reported a>t polymorphism in IVS6-4 of
COL11A2 (from OPLL studies in Japanese populations) did not show any significant
association between LSS and Finnish population. The authors justified this result by
stating the fact that OPLL is not prevalent among Finnish population, and that the
previously identified COL11A2 polymorphism is related to OPLL alone and not LSS in
general. However, the frequency of the t allele was significantly higher in probands
(93.1%) than the control group (72.3%). Further analysis showed that while the
frequency of t/a and a/a genotypes was not significantly varying between the probands
and controls, the t/t genotype had a much higher frequency in probands and had a
13

dominant effect. They estimated that 20% of the affected subjects in the population
could attribute their diseased state to the high-risk t/t genotype. Analysis of the other
previously reported polymorphisms in AGC1, VDR and MMP-3 genes showed no
significant differences in allele frequencies between the proband and control groups

20

.

Hyon et.al (2011) based their study on the findings of the Noponen-Hietala et.al. study
(2203). The authors studied COL9A2 gene as a candidate gene for LSS in the Korean
population

21

. Using MRI to establish phenotype, the study had 205 proband and 101

control subjects. The study identified 42 COL9A2 polymorphisms along with the
previously reported Trp2 allele found in Finnish population study

20

. Out of the 43 SNPs

identified, further analysis was done on the six that were present in the exons (and had
a minor allele frequency of at least 20%), but none were statistically significant that
could signal possible causal nature. This led the investigators to search for hidden
susceptibility alleles in COL9A2 for LSS by studying the haplotype structure of the gene.
The authors were able to identify the HAP2 haplotype (GCAGCG) overexpressed in
probands

(p=0.023

and

odds

ratio=1.86)

and

HAP4

haplotype

(TCAGCG)

overexpressed in controls (p=0.042 and odds ratio=0.52). The authors concluded that
COL9A2 does indeed play a role in lumbar spinal stenosis but the mechanism behind
this involvement remains unknown. The authors suggest a possible reason for this
observation – mutations in COL9A2 promoter region can affect the level of collagen IX
protein in relevant tissues by down-regulating expression 21.

Treatment
There is no cure for LSS. Management of the symptoms, either by surgery or
conservative means, is the only effective course of action

25

. The common perception is

that LSS is a progressive disease and conservative treatments are ineffective, only
surgery is effective and has long-term effectiveness

108 109

. Non-surgical treatments of

LSS have also shown some success for mild and moderate cases of LSS. However,
there are no standardized protocols for conservative management of LSS to guide
physicians. Medications are used to control the symptoms of pain and discomfort. This
includes analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants
14

and opioids. Dosage is based on individual cases and the discretion of the physician.
Physical therapy is an essential aspect of treatment of this disease. Exercise is believed
to condition the body against the deleterious effects that might be the result of inactivity
due to pain and discomfort. However there are several contradictory scientific reports
that either support or discredit this belief. Epidural injections are another form of pain
management. But the most commonly preferred form of treatment of LSS is neural
decompression surgery. This procedure usually involves the removal of thickened
connective tissue and/or osteophyte formations relieving the pressure on the nerve
tissue inside the spinal canal. In fact most studies on LSS focus on the before and after
aspect of neural decompression surgery. The success rate of surgery ranges from 26%
to 100% 110.

15

Lumbosacral stenosis
Anatomy of the normal canine lumbosacral spine
The anatomy of the spine in dogs is very similar to the anatomy of the spine in humans.
The arrangement and layout of the musculoskeletal elements follow a similar pattern.
However there is one distinct difference – the canine lumbar and sacral vertebral
segments are not separate entities as in humans, but are often considered to be one
single unit called the “lumbosacral” segment. The lumbosacral vertebral canal is
considered to be one continuous element comprising of the 5th to 7th lumbar (L5 to L7)
and the 1st to 3rd sacral (S1 to S3) in that order. Another difference from human
anatomy is the fusion of the three sacral vertebrae to form the sacrum. The vertebral
laminae, articular processes, pedicles and bodies of each of the L5-S3 vertebrae make
up the canal boundary. The space in between the caudal aspect of one vertebrae and
the cranial aspect of the adjacent vertebrae is the intervertebral foramen. The shape of
the vertebral canal in transverse profile is usually round or oval with the transverse
diameter tending to be greater than the dorso-ventral diameter

111

. The shape of the

lumbosacral canal becomes progressively semi-circular or crescent shaped as it
transitions from the cranial to the caudal end of the canal

112

. The cross-sectional area

of the canal is at its greatest at mid-lumbar level and gets progressively narrower both
cranially and caudally to that.
The spinal canal and the vertebral column start developing in the embryo together at the
same rate, but later on the vertebral column overtakes the spinal cord in the
development rate. This results in the vertebral column extending beyond the conus
medullaris (termination point of the spinal cord), so the nerves and nerve roots of
vertebrae towards the end of the spinal cord have to travel longer to exit caudally to
their corresponding vertebra. This forms a bundle of neural tissue called the “cauda
equina” residing in the empty space inside the vertebral canal caudal to the cord. The
dorsal and ventral roots of each spinal nerve have separate origins but unite to form a
single spinal nerve that passes through the intervertebral foramina and immediately
divides into dorsal and ventral branches. The ventral branches of the L4-S3 (L4, L5, L6,
16

L7, S1, S2 and S3) nerve roots contribute to the lumbosacral plexus, which controls the
hips, hind limbs, tail, urinary bladder, rectum, anus, and external genitalia. The
ligamentum flavum or interarcuate ligament (dorsally and dorso-laterally), intervertebral
discs and the dorsal longitudinal ligament (ventrally) form the soft tissue boundary of the
lumbosacral vertebral canal. The caudal ligament anchors the cord caudally. The
ligamentum flavum is a loose, elastic sheet that bridges the arches of adjacent
vertebrae in the dorsal vertebral canal. Laterally, it is continuous with the joint capsules
surrounding the articular processes. The intervertebral disc that sits between the
individual vertebrae consists of a central nucleus pulposus, and an outer annulus
fibrosus. The dorsal longitudinal ligament lies on the dorsal surfaces of the vertebral
bodies, in the ventral portion of the vertebral canal. It is narrow at the middle of the
vertebral body and wide over the intervertebral disc. The caudal ligament is a
continuation of the dura mater and attaches to the periosteum of the 5th or 6th caudal
lumbar vertebra.
The spinal branches of the lumbar arteries, which arise from the abdominal aorta,
supply arterial blood to the caudal spinal cord. The venous drainage for the spinal cord
is primarily through the internal vertebral venous plexus. The plexus consists of paired
interconnected vessels extending from the skull to the caudal end of the vertebral
column. These paired vessels lie inside the ventral side of the canal nestled among the
epidural fat. The spinal veins originate from the venous plexus following the same path
as the nerve roots, entering and exiting through the intervertebral foramina.
The caudal spinal cord and the cauda equina nerve roots are cushioned by three layers
of meninges, that together form the thecal sac. The meningeal layers consist of the dura
mater, arachnoid membrane, and the pia mater. The outer dura mater consists of
longitudinal collagen bundles that cover the cord and nerve roots as they exit the canal,
becoming continuous with the epineurium and perineurium of the spinal nerves. The
dura is separated from the periosteum of the vertebral canal by a wide epidural space
filled with fat. It is attached caudally to a point in the middle of the tail by the filum
17

terminale and the caudal ligament. The middle layer or arachnoid membrane is
separated from the inner pia mater by the subarachnoid cavity. This space is filled with
cerebrospinal fluid. The arachnoid membrane is joined to the underlying pia by
trabeculae. The pia mater is affixed tightly to the surface of the cord, and is usually one
cell layer. It is thickened laterally to form denticulate ligaments that attach the cord to
the dura. The thecal sac is more round than oval like the vertebral canal and the
diameters are at their greatest at the L4-L5 level, narrower cranial to L4 and wider
caudal to L5.
Etiology and pathogenesis
Lumbosacral stenosis (LS) is a multifactorial neuro-orthopedic disorder similar in nature
to human LSS 7. The classical definition of LS in dogs is – an abnormal narrowing of the
lumbosacral canal, vertebral canal, and/or the intervertebral foramina between the L5S3 segments that can lead to the compression of the neural and vascular tissues inside
the canal

7 8

. Cauda equina syndrome (CES)

113

is often a direct result of said

compression, so most of the clinical symptoms of LS often overlap with those of CES
114

. Canine LS also has multiple etiologies (similar to human LSS) –congenital

(developmental or idiopathic), or acquired (degenerative or post-traumatic)

7 115 5 116

.

Also similar to humans, acquired or degenerative LS is the most commonly observed
type of LS. However there is a theory that instead of any one distinct type of etiology,
canine LS might be a combination of two etiologies – both congenital and degenerative
117 4

. This theory is supported by the fact that most dogs start showing symptoms of LS

at a young age, well before degenerative changes should theoretically present
themselves. Another similarity with human LSS is that canine LS can also affect the
vertebral column across multiple vertebral levels, and affects not just the neural tissue
but also the vascular tissue – thereby also explaining the pathology behind intermittent
neurogenic claudication 118 62 65 119 60.
Some studies in humans have documented that individuals who get clinical signs of
LSS at a later age usually have pre-existing, subclinical bone malformations like
transitional vertebrae

120

. Lumbosacral transitional vertebrae (or LTV) is a common find
18

in dogs positive for spinal conditions like congenital LS

13 121 9 122

. The more common

degenerative form of LS usually results from a combination of several degenerative
changes including hypertrophied interarcuate ligament (ligamentum flavum), epidural
fibrosis, osteophytes, disc herniation or hypertrophy, spondylolisthesis and/or
spondylosis 115 5 116 114.

Clinical presentation
The most commonly observed neurological symptom of LS is intermittent lameness and
weakness in motor functions of the hindlmbs, which can progress to atrophy of the
hindlimb

muscles

and

paresthesia

(physically

inexplicable

sensation

of

tingling/tickling/pricking/burning of the skin). Paresthesia can in turn lead to selfmutilation of the hindlimbs, tail, perineum, anal area and genitalia that is unrelated to
any other dermatological condition. Other symptoms include vocalizing during exercise;
difficulty in standing up, sitting or lying down; low carriage of the tail; kyphosis
(abnormally excessive convex curvature of the spine); stiff or unnatural gait; dragging of
paws; hypotonia of the tail; and last but not the least urinary and fecal incontinence
124 125

123

. Most of these symptoms usually overlap with other neuro-orthopedic and/or

musculoskeletal disorders like cauda equina syndrome

116

, osteoarthritis

126

,

127

, and

intervertebral disc degeneration 128.
Even though Tarvin (1980) was the first to report LS in dogs, his study comprised of
mostly small breeds 7; since then a trend has been identified – LS usually affects largersized dog breeds
123 124 125

16 129 130

. German shepherds are the breed that is most represented

; but other high risk breeds include Labrador retrievers, Rottweilers, Bernese

Mountain dogs, Boxers, Dalmatians, Irish setters, and Doberman pinschers

130

.

Lumbosacral stenosis also appears to affect males more than females (again similar to
human LSS)

123 124 130 115 5 6 125

. Possible reasons for this gender-specific trend are:

male dogs are usually heavier in size, faster in their growth rate and are selected more
often for strenuous physical activity
years

5 6 123 124 125

123

. The average age of onset for LSS is around 7

.
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Clinical diagnosis and diagnostic imaging
The primary symptom presented by majority of dogs with degenerative LS is reduced
physical activity and pain sensitivity in the lumbosacral region (on external manual
palpation)

114

. However, positive diagnosis of degenerative LS can be complicated by

the subtle nature of the clinical signs: (i) symptoms might not appear until the dog
undergoes hard physical exertion; (ii) symptoms can mimic those of other spinal
diseases like intervertebral disc degeneration (IVDD) diseases
sacroiliac joint disease (DSJD)

132

, foraminal stenosis

133

131

, degenerative

, Schmorl’s nodes

134

; and (iii)

dogs being unable to vocalize pain, masking signs of pain especially the high-drive
breeds, and/or dogs asymptomatic at the time of examination. Another concern of
diagnosing LS in dogs based on clinical symptoms is the unreliable nature of how a dog
responds to pain or discomfort.
Diagnosis of LS is most commonly performed using CT and/or MRI because
conventional radiographs are usually unable to capture the spinal canal in the transaxial plane – where most of the signals for lumbosacral stenosis are present. Computed
tomography is a well-established non-invasive diagnostic imaging technique used for
evaluating the lumbosacral spine in dogs
lumbar spinal diseases like spina bifida
spine

73

135 111 115 136 112

137

,

, IVDD

138

, and has been used to study

and vacuum phenomenon of the

. The advantages of using CT over MRI in veterinary practices include: (i)

greater availability; (ii) lower cost; and (iii) shorter duration allowing for reversible
sedation instead of general anesthesia. Tarvin (1980) identified L6-L7 and L7-S1
transitional locations as the most at-risk vertebral segments for LS.

Qualitative and quantitative computed tomography characteristics
Fingeroth (1989) was the first to use CT for the clinical diagnosis of a spinal disease in
an English bulldog

137

. Since then CT has become a commonly used imaging technique

in dogs especially for spinal diseases. Jones et.al (1996) studied the CT anatomy of the
20

lumbosacral spine of 9 large breed dogs clinically diagnosed with LS, and then
confirmed the said imaging anatomy with surgical evaluation

139

. The commonly

observed CT abnormalities in these dogs (with surgically confirmed LS) were: loss of
epidural fat, increased soft tissue opacity, bulging in the intervertebral disc margin,
spondylosis, displacement of the thecal sac, narrowed intervertebral foramina, narrowed
vertebral canal, thickened articular processes, subluxation of the articular processes,
bone spurs in the articular processes, and telescoped sacral lamina. The authors
acknowledged the possibility that all these traits might not be true clinical signs of LS
since some of the traits were also detected in dogs with no signs of LS. However, the
study was able to identify 2 possible qualitative traits of LS – loss of epidural fat and
loss of soft tissue transparency that was observed in all of the 9 dogs positive for LS.
Other observed traits with a high frequency included disc bulging, spondylosis, and
thecal sac displacement (findings also supported by studies of human LSS). Epidural
fibrosis was another trait observed only in surgery but not directly in the CT images. An
ill-defined region of soft tissue opacity and loss of nerve root/thecal sac visualization
were the only observable characteristics of fibrosis in the epidural region in CT images –
cause and significance of which is not well understood in dogs

116 115

. Human studies

have suggested that epidural fibrosis might be a post-surgical complication rather than a
spontaneous phenomenon

135 82 83

,

. Some of the qualitative traits observed were not at

the exact site of neural compression but in adjoining vertebral segments, thus also
hinting at a possible multi-level etiology of canine LS 7. The clinical symptom of
neurological claudication has been attributed to this multi-level phenomenon in human
LSS 62 60.
Feeney et.al (1996) published a morphometric study to quantify the normal canine
lumbosacral spine

140

. The subjects in this study were three Beagles and three mixed-

breeds. The canal and foramen diameters as well the thecal sac diameters were
measured manually in transverse CT images. The average intervertebral foramen
diameter range was 0.20cm – 0.30cm. Epidural fat was found to be present on all
aspects of the thecal sac in all vertebral levels and no correlation was found between
21

epidural fat and body weight of the dog. To compensate for the difference in body size
of the different dogs, all the measurements were standardized based on the
measurement of the least variable L6 vertebral mid-body. Despite the standardization,
significant variation was observed among the six dogs. The vertebral canal was oval but
the thecal sac was more circular in profile, and the space within the canal that was not
occupied by the thecal sac was filled up by epidural fat. The authors proposed cautious
interpretation of the loss of epidural fat in the vertebral canal as a symptom of stenosis
139

, since it could just be normal anatomical adjustment instead of a clinical symptom.

However this study did not state any absolute values to define a normal lumbosacral
spine and only recorded for any significant differences among the dimensions measured
in the six dogs of the study. The morphometric study of the lumbosacral spine by Jones
et.al had a larger sample size of 42 large breed dogs (21 cases and 21 controls) and
included dogs from multiple breeds 112.
Genetic characteristics
The modern day dogs we observe today have become an essential part of the human
way of life 141. Dogs (Canis lupus familiaris) are in fact the domesticated sub-species of
the grey wolf (Canis lupus) 142. The oldest dog domestication records found date back to
approximately 15,000 years, but some studies argue that the first canine domestication
event could have happened up to 100,000 years ago in Eastern Asia 143 142 144. Humans
and dogs have evolved in parallel with each other over time 145, sharing living space and
food sources based on a mutually beneficial relationship – thus making the comparative
analysis of the human genome possible due to the shared environment which in turn led
to shared evolution

146

. This unique shared history among humans and dogs makes the

canine species a perfect model to explore the genetic basis of diseases, variation in
morphology and behavioral traits – with respect to not only how it affects the canine
species but also how similar disease processes might affect humans.
After the initial phase of domestication, dogs underwent extensive artificial selection due
to their intentional breeding by humans focused on fixing specific traits – resulting in the
creation of the breed structure seen in dogs today
22

147 148

. While there are a wide variety

of canine breeds, population structure within each breed is relatively homogenous and
is comparable to the population structure observed in geographically isolated human
populations148,149 150 151 147 152 153. And similar to human populations, certain dog breeds
have a higher prevalence for certain diseases than other breeds

154

. This further

enhances the desirability of the canine model for human biological research – diseases
with unknown etiology in humans are often first studied in smaller geographically
isolated population in which the disease has a higher than normal incidence, before the
findings can be translated to a larger population. Another factor that makes dogs such
good models is that most canine diseases also have a version that affects humans often
with similar clinical manifestations

155

. Other key factors that make dogs good models

for human disease studies include: 1) dogs usually enjoy high quality of medical care
alongside humans for similar medical conditions; 2) both being mammals, dogs and
humans are comparable to each other both anatomically and physiologically; 3) dogs
generally cohabit with humans thus negating the effects of differing environmental
exposures; 4) many human diseases occur naturally in dogs thus there is no need for
chemical or mechanistic techniques to artificially induce the disease state; and 5) dogs
have shorter life span, allowing for longitudinal studies to observe the progression of
diseases over time

156

. This unique relationship between dogs and humans, and the

success of the canine model for human disorders, would allow bidirectional beneficial
flow of information – findings in canine studies would not just benefit humans, but
finding in human studies could also be applicable in dogs

151

. Genetic analysis of a

diverse array of traits in dogs has provided further proof supporting this theory. The
canine genome has been completely sequenced by the Broad Institute in 2003 149. More
than 650 million base pairs (more than 25%) of the dog sequence align uniquely to the
human genome including orthologs for 18,473 of the 24,567 annotated human genes
157

. For certain traits the dog genome is more similar to humans that the common rodent

models 158.
Some genetic factors (especially those dealing with collagen genes) have been implied
to be playing a role in LSS in some geographically isolated human populations in
23

previous studies

20 21

. No such genetic studies have been conducted in dogs except a

pedigree association study of LS in German shepherds

11

. However to the best of our

knowledge, no genetic association study has been reported that focuses on LS in
Labrador retrievers. The canine model has found success in study of several human
musculoskeletal diseases that include intervertebral disc disease (IVDD)
Muscular Dystrophy (DMD)

160

; and osteoarthritis (OA)

161

159

; Duchenne

. Quantitative diagnostic

imaging has been used to study other human diseases in canine models in diseases
like ischemic renal disease

162

. Experimental bone regeneration has also found some

success in the canine model in recent years
experimental canine model for LSS in 1990

165

163 164

. Delamarter et.al introduced an

. However, larger sized breeds like the

German shepherds and Labrador retrievers would make them better models for LSS,
since the disease process of LS in these breeds is more organic and natural.

Treatment
Tarvin (1980) was the first to report treatment plan for LS in 15 dogs 7. The dogs were
treated conservatively with anti-inflammatory drugs and Elizabethan collars (or Ecollars) to prevent the dogs from self-mutilating themselves. Similar to LSS in humans,
the most popular treatment approach is surgical – decompression by deep dorsal
laminectomy in combination with lateral foraminotomy of the affected vertebrae

7 166

.

Laminectomy and foraminotomy both involve the removal of hypertrophied tissue to an
extent that the neural tissue inside the vertebral column is no longer compressed
thereby also relieving the pressure on the vascular tissue. The treatment strategies
have not changed much over the last 30 or so years

167

. Non-surgical therapy still

involves oral analgesics or anti-inflammatory drugs to provide symptomatic pain relief
(again similar to the approach used in majority of human subjects that present with
LBP).
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Table II.1. Major causes of lumbar spinal stenosis in humans
Congenital/developmental
Idiopathic
Achondroplasia/hypochondroplasia
Hypophosphatemic vitamin-D resistant rickets
Morquio’s mucopolysaccharidosis
Spinal dysraphism
Acquired
Degenerative
Spondylosis
Spondylolisthesis
Scoliosis
Ossification of posterior longitudinal ligament
Ossification of ligamentum flavum
Intraspinal synovial cysts
Post-operative
Laminectomy
Fusion
Post-traumatic
Metabolic
Cushing’s disease
Osteoporosis
Acromegaly
Pseudogout
Renal osteodystrophy
Hypoparathyroidism
Other
Paget’s disease
Rheumatoid arthritis
Ankylosing spondylitis
Diffuse idiopathic skeletal hyperostosis
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CHAPTER III. PHENOTYPIC CHARACTERIZATION OF LUMBOSACRAL STENOSIS
IN LABRADOR RETRIEVERS
III.1: Introduction
The definition of lumbar spinal stenosis (LSS) is the structural narrowing of the lumbar
spinal canal, nerve root canal and/or intervertebral foramina

168 17

. Clinical symptoms

may arise when this narrowing results in compression or entrapment of the underlying
nerve tissue, meninges and/or blood vessels inside the vertebral canal

168 66

. Lumbar

spinal stenosis can be confined to a single vertebra or spread across multiple vertebral
levels 169

170 17 171 172 173 174

. Lateral canal or foraminal stenosis is a specific type of LSS

that involves the lateral portions of the vertebral canal or intervertebral foramina. Based
on the time of onset, LSS can also be classified as either primary stenosis (narrowing
due to congenital or developmental malformation) or acquired stenosis (narrowing due
to encroaching proliferative tissues and/or vertebral malalignment).

Acquired or

degenerative causes of stenosis include facet joint arthrosis or hypertrophy, thickening
and bulging of the intervertebral disc, hypertrophy of the ligamentum flavum and/or
spondylolisthesis. Some studies have also implicated genetics as a factor in the
pathogenesis of human LSS 20 21.
The canine version of LSS is known as lumbosacral stenosis (LS) 7. The larger sized
working/sporting breeds of dogs are predisposed to LS

8 123 16 175 129 115 5 6 24 112 139

.

Labrador retrievers are the most popular household pet dog breed in the United States
15

and also one of the most common breeds used worldwide as working dogs

176

. This breed is also considered to be at high-risk for LS 130.

123 16 3

X-ray computed tomography (CT) is an accepted non-invasive method for deep
phenotyping of LSS in humans 177 178 89 179 77 75 44 180 83
LS in dogs

186 187 188 189 16 190 79

181 182 91 71 183 184 185

; as well as

. The current standard CT methods for phenotypic

characterization of LS in dogs are based on qualitative observations made in dogs with
26

surgically confirmed presence of LS

139 191 129 16 190

. These criteria include loss of

epidural fat, increased soft tissue opacity, bulging of intervertebral disc, spondylosis,
thecal sac displacement, narrowed intervertebral foramen, narrowed vertebral canal,
narrowed articular processes, articular process subluxation and articular process
osteophytosis

139

. For research purposes, quantitative criteria for phenotyping LS would

be desirable because they would allow for use of more powerful parametric statistical
tests.
Quantitative CT measures of human LSS have been extensively described, however
traits measured and values used for defining stenosis have varied between reports 178 76
86 75 192 91 193 30 194

. Cross-sectional vertebral canal area, antero-posterior diameter and

inter-pedicular diameter measurements of the spinal canal are the most commonly
described quantitative traits in humans 75

179 86 92 192 83 78 195 90 196

. Other measurements

reported include the following: mid-sagittal vertebral canal diameter, lateral recess
sagittal diameter, transverse thecal sac area, inter-facet ligamentous diameter and
thecal sac diameter.

Cross-sectional area measurements offer an advantage over

diameter measurements because they are more likely to detect asymmetrical canal
narrowing or lateral canal narrowing

86 75 91 92 90

. However, despite the established

definition of stenosis being “narrowing”, there are very few evidence-based reports
where the “stenotic” vertebral canal area range has been defined, or compared with
“normal” area measurements

86

, or the threshold value agreed upon. The contradictory

threshold values for a stenotic canal range anywhere from 0.85 cm2 83 to 1.45 cm2
Another study assigned 1.4 cm2 as the stenosis threshold

90

75

.

. No such studies exist in

dogs that focus on quantitatively differentiating between “stenotic” and “non-stenotic”
canals. There is one previous canine study that did a morphometric comparison
between quantitative CT characteristics of the lumbosacral vertebral canal in dogs with
versus without symptoms of cauda equina dysfunction

112

, but not LS. Vertebral canal

diameter and area values were found to correlate with adjacent vertebral body
dimensions in asymptomatic dogs, therefore ratios of vertebral canal and vertebral body
measurements were used to correct for variations in dog body size in subsequent
27

comparisons.

Differences between groups were found for ratios of vertebral canal

transverse area to vertebral body transverse area at caudal L5 (0.42 LS, 0.46 control)
and caudal L6 (0.36 LS versus 0.44 control). However, this study included dogs from
multiple breeds and the study was able to quantify only bony canal stenosis (soft tissue
stenosis was not quantified). Also, at the time of the previous study, availability of
advanced CT image analysis softwares that allow for both manual and automated
measurements of selected structures of interest were limited.

To the authors’

knowledge no published reports have compared CT quantitative measures to qualitative
assessments of LS.
The aims of this current study were to develop a CT quantitative method for
characterizing the morphologic phenotype of LS in Labrador retrievers and to compare
findings from this method with findings from current standard qualitative CT methods.
The hypotheses of this study were: 1) ratios of CT vertebral canal transverse area to
vertebral body transverse area, and novel ratios of vertebral canal transverse epidural
fat content area to vertebral body transverse area can be used to quantify LS in
Labrador retrievers; and 2) the assessment of LS made using these quantitative
measurements will yield results comparable to the current standard qualitative
assessment of LS.
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III.2: Materials and Methods
Study samples
This cross-sectional retrospective study was based on CT scans and medical records of
Labrador retrievers obtained from three sources: the Holland Military Working Dog
Hospital at the Lackland Air Force Base, Virginia-Maryland Regional College of
Veterinary Medicine Veterinary Teaching Hospital and the University of Pennsylvania
Ryan Veterinary Hospital/Working Dog Center. A board certified veterinary radiologist
(JJ) reviewed the scans to ensure they met inclusion criteria. The scans had to contain
the lumbosacral region and evidence of no previous lumbosacral surgery, neoplasia,
fractures or infection in order to be included in the study.

Computed Tomography
All included scans were analyzed using CT image analysis freeware (OsiriX DICOM
Viewer, Version 4.2) and image analysis workstations (Mac Pro and MacBook Pro Apple
Inc. Cupertino, CA). Under the supervision of a board-certified veterinary radiologist (JJ),
a single observer (MM) independently measured and recorded quantitative values while
unaware of qualitative CT findings and medical history. After a delay period, the
veterinary radiologist then recorded a qualitative diagnosis of presence or absence of LS
at each of the vertebral locations using standard criteria. At the time of interpretation, the
radiologist was unaware of quantitative or medical record findings. After quantitative CT
measurements were completed, the same observer (MM) then made note of the age,
sex, body weight, low back pain (LBP) status and working status; as entered into the
medical records at the time of the original CT scan.
Slice thickness for each study was standardized at 5 mm using the software’s “thick slab
mean mode” tool in order to maximize contrast resolution for soft tissues and minimize
sources of partial volume averaging variability between studies

197 135

. The following

quantitative CT phenotypic variables were measured in triplicate at each of six vertebral
locations previously established as the lumbosacral region primarily affected by LS
29

(caudal L5, cranial L6, caudal L6, cranial L7, caudal L7 and cranial S1) 7 139 (Figure III.1):
vertebral canal area, vertebral body area and vertebral canal fat area. Vertebral canal
area at each vertebral location was measured using a bone window setting (WL 300,
WW 1500) tracing the canal boundary with a pencil tool ensuring the surrounding bone
did not get included inside the tracing (Figure III.2A). Using the same pencil tool and
window setting, the vertebral body area was traced ensuring that no surrounding soft
tissue was included. The vertebral canal fat area at each vertebral location was
measured in a soft tissue or “abdomen” window (WL 40, WW 350), using segmentation
tools to set the lower and upper threshold at -200 and 0 Hounsfield units (HU)
respectively (Figure III.2B). A region of interest (ROI) was generated automatically by
clicking the cursor over all locations within the canal where fatty tissue appeared to be
present (visibly darker color grey than other soft tissue). All area values were measured
in cm2. The means of all triplicate measurements were calculated. Vertebral
canal/vertebral body area ratio (CAR)

112

and canal fat area/vertebral body area ratio

(FAR) (novel methodology) were then calculated from the means at each location for
each dog.
Canal stenosis was qualitatively assessed and recorded as present or absent for each
dog at each of the six vertebral locations. The assessment was done twice in two
separate reading sessions by the same veterinary radiologist (JJ). To minimize read
bias, scans were interpreted in random order and the second reading session was done
three days later, at a different time of day and in a re-randomized order. In cases where
there was a discrepancy between the first and second readings, the radiologist made a
third assessment that was deemed to be the final decision. For purposes of this study,
qualitative stenosis at a vertebral location was considered to be present if the radiologist
detected at least two of the following CT lesions: thickened pedicle(s), thickened
lamina(e), loss of epidural fat on opposing sides of neural tissue, proliferative bone or
soft tissue in the canal and/or a subjectively narrowed canal
considered to be absent if one or no lesions were detected.
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7 175 198

. Stenosis was

Statistical analyses
A single statistician (IH) selected and performed statistical tests using commercial
software (JMP®, Version Pro 11, SAS Institute Inc., Cary, NC, Copyright© 2013). Dogs
were grouped under the following clinical data categories for analyses: sex – M (male)
or F (female); LBP status – absent or present; and working status – working or nonworking. Age and weight were treated as continuous variables. Significance criterion
alpha for all tests was set at 0.05 (5%). Initially, continuous variables such as canal area
ratios (CAR) and fat area ratios (FAR) for each of the 6 vertebral locations in all dogs
were screened for normal distribution using the Shapiro-Wilk W test

199

. Lack of

normality was detected in CAR for L5Cd, L6Cd and L7Cd. Negative inverse (-1/x)
transformation was applied to L5Cd, while L6Cd and L7Cd were natural log ln(x)
transformed. Variance equality in CAR and FAR between LS positive and LS negative
dogs (assigned based on CT image analysis) were inspected using Levene’s test 200. Ttests were used to test the null hypotheses: both quantitative measurements (CAR and
FAR, independently) are not different in LS positive from LS negative dogs (based on
the qualitative CT assessment). Secondary analysis included logistic regression with
dichotomous response

201

– LS positive or LS negative based on qualitative CT

assessment, where CAR and FAR were applied as explanatory continuous variables to
predict the presence or absence of LS, done individually for the 6 different vertebral
locations in the lumbosacral spine. Logistic regression analysis allowed the examination
of the variables (CAR or FAR), as to which quantitative measurement would be the
better predictor for the probability of being LS positive based on the CAR (or FAR)
measurements at a specific vertebral location. The predicted probability curves of LS
based on logistic regression were generated for each location. Untransformed data
were used for plot constructions. Significance was defined as p < 0.05 after BenjaminiHochberg correction with a false discovery rate (FDR) of 20% 202.
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III.3: Results
Study samples
This analytical cross-sectional retrospective study comprised of CT scans collected
between the period of 1997 and 2013, and included scans from a total of 25 Labrador
retrievers that met the inclusion criteria. The scan of one of the 25 dogs in the study,
included only four of the six vertebral locations (L6 caudal, L7 cranial and caudal, and
S1 cranial). For the two missing locations (5th caudal and 6th cranial lumbar vertebra),
analyses were performed on 24 dogs. The study involved 17 males and 8 females.
The ages of the subjects ranged from 11 months to 14 years (mean 6.46 ±0.84 years).
Dog weights ranged from 23.6 kg to 44 kg (mean 32.3 ±1.13 kg). 9 dogs showed signs
of lower back pain at the time of CT examination. Six of these 9 dogs were older than 5
years of age. The remaining 16 dogs had no signs of lumbosacral pain. Eight dogs were
classified as working dogs and the other 17 as non-working dogs. No significant
correlation between age and LBP was found. The study sample population is described
in Table III.1.

Computed Tomography scans
Twelve dogs were scanned with single slice CT scanners (IQXtra or PQ5000, Picker
International, Cleveland, Ohio) and 13 dogs were scanned with multi-slice CT scanners
(Aquilion, Toshiba, Tustin, CA; LightSpeed VCT or BrightSpeed, GE Medical Systems,
Pewaukee, WI). All single slice scans were acquired in axial mode and all multi-slice
scans were acquired in helical mode. The scan matrix for all dogs was 512 x 512.
Volume scans were acquired at 0.625 mm slice thickness for 7 dogs, 1 mm slice
thickness for 2 dogs, and 2 mm slice thickness for 1 dog. Contiguous scans were
acquired at 5 mm slice thickness for 2 dogs and 0.5 mm slice thickness for 1 dog.
Scans with a 1 mm overlap were acquired at 2 mm slice thickness for 2 dogs, 5 mm
slice thickness for 9 dogs, and 4 mm slice thickness for 1 dog. A standard scan filter
was used for 18 dogs, detail/bone filter for 6 dogs, and body filter for 1 dog. Technique
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settings were 13-400 mA and 120-140 kVp. All the CT scans were acquired from dogs
positioned in dorsal recumbency.

Statistical analyses
Based on the performed t-tests, the mean CAR values at the cranial end of the L7
vertebra in LS positive dogs was significantly smaller than the mean CAR of LS
negative dogs (p-value=0.0409). There was no statistically significant difference in
CARs between the LS positive and LS negative dogs at any of the other 5 locations
(Table III.2) (Figure 3). The t-tests for mean fat area ratios (FARs) indicated that FARs
for LS positive dogs were significantly smaller than FARs for LS negative dogs across
all 6 vertebral locations (Table III.2) (Figure 4). Logistic regression analysis between
quantitative CAR measurements and qualitative CT diagnoses of LS (standard test)
showed no statistical significance at any of the six vertebral locations (Table III.3) (data
not shown). Logistic regression between quantitative FAR measurements and the same
qualitative CT diagnoses showed statistically significant associations at each of the six
vertebral locations (Table III.3) (Figure 5). Predicted probabilities for LS positive dogs (y
axis) against FAR measurements (x axis) for all six locations were plotted based on our
model and are represented in Figure 6. All of the predicted probability curves had high
R2 values (L5Cd=0.999; L6Cr=0.997; L6Cd=0.998; L7Cr=0.998; L7Cd=0.991; and
S1Cr=0.997) and displayed a pattern of increase in the probability of being LS positive
with decreasing FAR values.
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III.4: Discussion
The purpose of this study was solely to develop a quantitative CT method for structural
phenotyping of LS (that could be comparable with traditional qualitative detection
methods) in Labrador retrievers – facilitating research related statistical analysis, and
not diagnosis of LS for clinical applications. Clinical detection of lower back pain can be
unreliable as an outward indicator of LS in dogs, especially in stoic and high-drive dogs
such as Labrador retrievers. Hence the need for deep phenotyping using advanced
imaging modalities like CT and MRI. While qualitative assessment of scanned images is
the standard for clinical applications with regards to LS in dogs, statistical analyses are
strengthened with quantifiable variables.
Our first hypothesis was that quantitative CT measurements could quantify LS in
Labrador retrievers. We started with two measurements: canal area ratio (CAR) and fat
area ratio (FAR), however the most significant results were achieved by the novel
measurement (FAR) in quantification of LS. Stenosis has been defined as narrowing of
the spinal canal, CAR was assumed (and has been used in previous studies 112) to be a
vital numerical measurement that could signal stenosis. Transverse canal area ratios
were used instead of absolute values to compensate for difference in body sizes of the
dogs (bigger dogs have bigger vertebral canals and vertebral bodies; and vice versa).
Loss of epidural fat at the location of stenosis has also been reported as one of the
most frequently observed CT lesions for surgically confirmed stenosis in dogs

139

. To

compensate for the difference in body sizes of the dogs and be comparable to CAR (the
other measurement), we chose to use FAR (fat-content transverse area with vertebral
body transverse area) instead of the absolute values.
Our second hypothesis was that the assessment of LS made by CT quantitative
measurements would yield results comparable to current standard qualitative CT
assessment of LS in Labrador retrievers. Findings supported one part of our hypothesis
but not the other. The previously reported quantitative measurement (CAR) did not
34

show statistically significant agreement with the qualitative assessment made by the
board certified veterinary radiologist. However, the novel quantitative measurement
(FAR) had significant agreement with the standard qualitative assessment of LS. Canal
area ratio was found to differ at some vertebral locations in dogs with versus without
signs of cauda equine nerve dysfunction

112

, however to our knowledge, no previous

papers have compared quantitative and qualitative CT characteristics of stenosis in
dogs. There are no reported threshold values for any quantitative traits that measure LS
in dogs. The predicted probability curves (based on logistic regression between LS and
FAR measurements) supported our study hypothesis in that a decrease in the FAR at a
vertebral canal location (L5Cd, L6Cr, L6Cd, L7Cr, L7Cd and S1Cr) increased the
probability of the vertebral location being classified as LS positive by an expert reader.
These probability plots provide preliminary evidence that FAR threshold values may be
used for determining LS positive or negative status at individual vertebral locations in
Labrador retrievers. Further investigations in larger samples of Labrador retrievers are
needed to establish the FAR threshold values for LS status in this breed, at each of the
vertebral locations of the lumbosacral spine. The process could also be repeated in
other breeds of dogs to develop breed-specific FAR threshold values.
This study had the following limitations: small sample size, manual tracing
measurements of vertebral canal area and vertebral body area, use of only one
radiologist for qualitative assessment and only one observer for the quantitative
measurements, and different CT technique settings used at the time the scans were
acquired. Our choice to focus on Labrador retrievers limited our sample size, but helped
minimize outside variability due to breed differences that could have interfered with our
analyses. We attempted to maximize the sample size by seeking cases from 3 different
hospitals. We also included a dog whose scan covered only four of the six locations, to
maximize the sample size for the available four locations.
The study had roughly equal number of LS positive and LS negative dogs (11 LS
negative and 14 LS positive). Dogs older than 5 were overrepresented in the LS positive
35

	
  

group (average age = 8.07 ± 0.99). Males were affected more than females in the LS
positive group (in agreement with previous reports). Low back pain status did not have
good agreement with LS status (also consistent with previous reports). Only 6 of the 14
LS positive dogs were also LBP positive, and 5 out of these 6 dogs were older than 5
years of age. Findings subjectively supported the theory that younger LS positive dogs
may not initially present with clinical signs of LBP and that the likelihood of lower back
pain detection may increase with age, however no statistically significant association
could be demonstrated due to small sample size. Small sample size also inhibited the
testing of associations between qualitative LS assessments and any of the other
demographic data – none were significant.
Making triplicate measures and using an average of these measures for analyses
minimized observer effects in manual measurements. Using only one observer for the
measures and one radiologist, another external source of variability was minimized.
However this prevented us from performing inter-observer repeatability tests for the
methodology. Being a retrospective study, the study had no control over the technical
CT settings used at the time of the scan – another possible source of external
variability. But this could also be an advantage since the results can be applicable to a
wide range of CT settings. Attempts were made to reduce variability due to different
technical settings by standardizing the settings in the image analysis freeware (Osirix)
while making measurements. So, findings from the current study indicate that CT FAR
measurements yield comparable results to qualitative CT assessment of LS by an
expert reader for Labrador retrievers. Further studies are needed to verify the efficacy of
FAR as a research tool for quantitative phenotyping of LS in Labrador retrievers as well
as in other breeds of dogs.
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Figure	
  III.1.	
  

Figure III.1. Positioning of a dog for acquiring CT scan of the lumbosacral spine.
Photograph of a Labrador retriever positioned for CT scanning of the lumbosacral spine.
The dog is under general anesthesia and positioned in dorsal recumbency on the CT
table with the hind limbs flexed in order to flatten the lumbosacral angle.
Credit: Veterinary Teaching Hospital, Virginia-Maryland College of Veterinary Medicine
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Figure	
  III.2.	
  

Figure III.2. Lateral CT image depicting the six measured locations of the canine
lumbosacral spine
Lateral localizer CT image of the lumbosacral region illustrating the locations where
canal and fat area measurements were acquired. L5 Cd = caudal portion of the 5th
lumbar vertebra, L6 Cr = cranial portion of the 6th lumbar vertebra, L6 Cd = caudal
portion of the 6th lumbar vertebra, L7 Cr = cranial portion of the 7th lumbar vertebra, L7
Cd = caudal portion of the 7th lumbar vertebra and S1 Cr = cranial portion of the 1st
sacral vertebra.
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Figure	
  III.3.	
  

Figure III.3. Representative screenshots illustrating the methodology for the quantitative
measurements
(A) Transverse bone window CT image of the lumbosacral spine at L6 caudal location
illustrating the regions of interest (ROI) that were hand-drawn for vertebral canal area
and vertebral body area measurements (B) Transverse soft tissue window CT image of
the lumbosacral spine at the same location in the same dog illustrating the automated
ROIs that were generated for vertebral canal fat area measurements.
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Figure	
  III.4.	
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Figure III.4. Mean canal area ratio comparisons between LS-positive and LS-negative
dogs. Significant difference (p ≤ 0.05) is denoted by (*). N = 25 except at 5th caudal and
6th cranial lumbar vertebra (n = 24) (Ψ).
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Figure	
  III.5.	
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Figure III.5. Mean fat area ratio comparisons between LS-positive and LS-negative
dogs. Significant difference (p ≤ 0.05) is denoted by (*). N = 25 except at 5th caudal and
6th cranial lumbar vertebra (n = 24) (Ψ).
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Figure	
  III.6.	
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Figure III.6. Logistic regression between quantitative measurements and qualitative
assessment of lumbosacral stenosis
Logistic regression between the quantitative fat area ratio measurements and the
qualitative CT diagnoses of lumbosacral stenosis for each of the six vertebral locations
(A) L5Cd: caudal end of 5th lumbar vertebra; (B) L6Cr: cranial end of 6th lumbar
vertebra; (C) L6Cd: caudal end of 6th lumbar vertebra; (D) L7Cr: cranial end of 7th
lumbar vertebra; (E) L7Cd: caudal end of the 7th lumbar vertebra; (F) S1Cr: cranial end
of the 1st sacral vertebra
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Figure	
  III.7.	
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Figure III.7. Predicted probabilities for being LS-positive at each of the six vertebral
locations
Probability of being LS-positive has been predicted based on the logistic regression
analysis between the novel quantitative measurement of stenosis (fat area ratio or FAR)
and the standard qualitative CT diagnosis of being LS-positive for each vertebral
location (A) L5Cd: caudal end of 5th lumbar vertebra; (B) L6Cr: cranial end of 6th lumbar
vertebra; (C) L6Cd: caudal end of 6th lumbar vertebra; (D) L7Cr: cranial end of 7th
lumbar vertebra; (E) L7Cd: caudal end of the 7th lumbar vertebra; (F) S1Cr: cranial end
of the 1st sacral vertebra.
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Table III.1. Clinical data demography of the study samples

Group

CT LS negative

CT LS positive

Number

11

14

Average Age

4.45 (± 1.08)

8.07 (± 0.99)

Age Range

1 - 11

1 - 14

Sex

8 M, 3 F

9 M, 5 F

Average Weight

31.35 (± 1.22)

33.07 (±1.69)

Weight Range

25.7 - 40.4

23.6 - 44.0

Working status

6 W, 5 NW

2 W, 12 NW

Low back pain (LBP) status

3 positive, 8 negative

6 positive, 8 negative

Legend:
CT – computed tomography

LS – lumbosacral stenosis

M – male

F – female

W – working

NW – non-working
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Table III.2. T-test p-values for canal area ratio and fat area ratio comparisons
between LS-positive and LS-negative dogs

Vertebral location

T-test p-values
Canal area ratio (CAR)

Fat area ratio (FAR)

5th Lumbar caudal (L5_Cd)

0.2201Ψ

0.0391* Ψ

6th Lumbar cranial (L6_Cr)

0.6205 Ψ

<0.0001* Ψ

6th Lumbar caudal (L6_Cd)

0.0723

0.0054*

7th Lumbar cranial (L7_Cr)

0.0409

0.0010*

7th Lumbar caudal (L7_Cd)

0.4287

0.0049*

1st Sacrum cranial (S1_CR)

0.1037

0.0005*

N = 25 dogs except where denoted by Ψ (n= 24 dogs)
Difference was defined as significant (*) when p < 0.05 after Benjamini-Hochberg
correction.
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Table III.3. Logistic regression p-values – quantitative measurements (CAR and
FAR) and qualitative CT assessment of stenosis

Vertebral location

Logistic regression p-values
Canal area ratio (CAR)

Fat area ratio (FAR)

5th Lumbar caudal (L5_Cd)

0.4564 Ψ

0.0390* Ψ

6th Lumbar cranial (L6_Cr)

0.7251 Ψ

0.0003* Ψ

6th Lumbar caudal (L6_Cd)

0.3467

0.0449*

7th Lumbar cranial (L7_Cr)

0.0685

0.0011*

7th Lumbar caudal (L7_Cd)

0.9307

0.0008*

1st Sacrum cranial (S1_CR)

0.1799

0.0011*

N = 25 dogs except where denoted by Ψ (n= 24 dogs)
Significance is denoted by (*) when p ≤ 0.05 after Benjamini-Hochberg correction.
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CHAPTER IV. GENETIC CHARACTERIZATION OF LUMBOSACRAL STENOSIS IN
LABRADOR RETRIEVERS

IV.1: Introduction
Working dogs are high-performance athletes and vital members of teams that support
public service, national security and military missions in the U.S. and around the world
1

. Working dogs perform a variety of tasks such as sentry-and-patrol duty; search and

rescue; mobility support for disabled persons; and detection of explosives, arson
accelerants, illegal drugs. Labrador retrievers are one of the most popular choices for
use as detection dogs

3,14

. The demands for detection dogs have been increasing over

recent years 3. In particular, military forces worldwide recognize military working dogs
(MWDs) as “force multipliers”. An American Forces Press Service release (October,
2015)

estimated

the

US

military

to

have

around

2,300

MWDs

(http://usmilitary.about.com/od/jointservices/a/militarydogs.htm). The dogs represent all
branches of the military, and together with their handlers they are deployed worldwide to
serve American interests. All branches of the U.S. military consider MWDs to be vital for
accomplishment of their missions and invest major financial and personnel resources
each year to procure, train and maintain these working dogs. According to a 2011 US
Government Pentagon memo, typical purchasing and training costs for a high quality
MWD can range anywhere in between $20,000 to $40,000 US dollars (depending on
the nature of MWD’s assignments, and whether the dog is trained for multiple types of
tasks) (http://www.nytimes.com/2011/05/12/world/middleeast/12dog.html?_r&_r=0). The
demand for high quality dogs working dogs is increasing; along with the cost of
breeding, raising and subsequent training of the dogs. This has resulted in a decrease
in the availability of new dogs. Therefore, ideally the military needs to have dogs that
can maintain functionality for as long as possible. Once they are trained, the service
lifetime of a typical MWD is expected to average about 10 – 12 years of age
(http://todaysmilitary.com/videos/a-military-working-dog-handler). Early retirement of a
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trained MWD would mean not just a financial loss for the US Military, but also a
functional loss for the productivity of the team that depends on the particular dog.
Spinal diseases are one of the leading causes for early retirement in MWDs
2

. Lumbosacral stenosis (LS) is the most common pathological condition that affects

the canine lumbosacral spine, especially the large breed dogs like German shepherds
and Labrador retrievers
affected by LS

16
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. Labrador retriever MWDs are also

. Lumbosacral stenosis in dogs is defined as an abnormal narrowing of

the lumbosacral canal, vertebral canal, and/or the intervertebral foramina

7

. This

morphologic problem is a risk factor for disability due to compression of the underlying
neural and/or vascular tissues. This compression can in turn be a risk factor for clinical
conditions such as cauda equina syndrome (CES) 8. Low back pain (LBP) on palpation
of the lumbosacral spine is the primary clinical sign of LS in the majority of dogs

114

.

However, disadvantages of diagnosing LS based on LBP status alone include the
following: (i) symptoms can be intermittent with appearance only after hard physical
exertion; (ii) symptoms can mimic those of other spinal diseases like intervertebral disc
degeneration (IVDD) diseases
foraminal stenosis

133

131

, degenerative sacroiliac joint disease (DSJD)

, and Schmorl’s nodes

134

132

,

; (iii) stoic dogs may not consistently

vocalize pain; and (iv) Labrador retrievers are specifically bred to be stoic and have
high-drive – qualities desirable for the MWD job description but can also cause a delay
in detection of sub-clinical conditions like LS. A dog can be structurally LS positive, but
clinical signs can be absent until the condition worsens to such an extent that
therapeutic and surgical options are no longer viable, and the only course of action for
the military is retirement (and in severe cases euthanasia). Therefore improved
methods for early detection of LS are critical for minimizing the risk of early retirement in
these valuable canine athletes.
Computed tomography (CT) is a well-established non-invasive diagnostic imaging
technique used for clinically diagnosing LS in dogs

136 188

. The commonly observed CT

abnormalities in dogs with surgically confirmed cases of LS include: loss of epidural fat,
50

increased soft tissue opacity, bulging in the intervertebral disc margin, spondylosis,
displacement of the thecal sac, narrowed intervertebral foramina, narrowed vertebral
canal, thickened articular processes, subluxation of the articular processes, bone spurs
in the articular processes, and telescoped sacral lamina 139. Quantitative phenotyping of
LS using canal area measurements in large dogs of multiple breeds have also been
previously reported and correlated with clinical cauda equina syndrome

112

. However,

unless a dog presents with clinical signs of pain or discomfort, expensive imaging
studies such as CT are not routinely performed and the condition can go undetected
until the damage is irreversible. Therapeutic interventions are more effective in younger
military working dogs with LS and mild clinical signs, and more likely to achieve a
successful return to active duty status

16,187

. In humans, CT is an established technique

for qualitative and quantitative “deep phenotyping” of structural abnormalities before
they cause clinical disease. Examples include valvular calcification and aortic stenosis
in heart valve disease

203

, airway obstruction and parenchymal destruction in chronic

obstructive pulmonary disease or COPD
abnormalities in cystic fibrosis

206

113

, emphysema
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and bone density

. Computed tomography has also been used for

qualitative phenotyping and making in vivo measurements of bones in experimental
mouse models 207.
An improved understanding of the genetic mechanisms underlying LS would also be
highly beneficial for reducing the risks of early retirement in working dogs. Similar to the
orthologous human condition of lumbar spinal stenosis (LSS), canine LS has two
distinct etiologies: either congenital (idiopathic and developmental) or the more common
acquired (degenerative and post-traumatic)

17

. Studies have reported association

between genetic polymorphisms in collagen genes (COL9A2 and COL11A2) and
degenerative LSS in humans

20 21

. Developmental human LSS is usually observed in

individuals affected by achondroplasia 93, and has known genetic causes 208. Canine LS
studies have also suggested that LS might have genetic influences that can manifest
itself at an early age

9

11

. This genetic predisposition has been predominantly

accounted for by the congenital anomaly of lumbosacral transitional vertebra (LTV) – an
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abnormally formed vertebra usually between the last lumbar and first sacral vertebra

12

13

. Presence of LTV can often cause CES due to abnormally narrow spinal canal (LS)

10

. However no genomic exploration studies investigating the genetics of LS in Labrador

retrievers could be found at the time of manuscript preparation.
Genetic variation is the most common factor underlying most disorders – for both
Mendelian and non-Mendelian (complex) disorders

209

. In fact, of all known Mendelian

disorders that have been studied and the causes identified (around 2,600),
approximately 85% are due to mutations in the coding region or the “exome”

210

.

Genome wide association studies (or GWAS) have been the most widely used
approach to study the complex disorders

211

. However, most GWAS, even the large

scale ones, have been unable to explain the entire contribution of genes to most
diseases

212

, and often the most significant variant detected is not always the actual

causative locus

213

. The underlying reason for this limitation is that even though GWAS

can detect multiple genes in most complex diseases, it cannot account for the
interaction of the multiple genes with each other and with the environment

214

.

Furthermore, each of the identified risk alleles in most complex disorders usually has
small effects
effects

217 218

215 216

, suggesting the presence of other rare variants with relatively larger

. Theoretically, including the full sequence data and increasing the sample

size should overcome this limitation, but the process would be computationally and
statistically complicated

213

. Another disadvantage of GWAS is the requirement of large

sample sizes, a factor that can be a disadvantage in exploratory studies – both due to
cost and logistics. Whole exome sequencing (WES) is a better alternative approach for
exploring the underlying genetic mechanisms of both Mendelian disorders and complex
multi-factorial diseases

219 220 216

. Since coding regions constitute approximately 1% of

the whole genome, WES is an efficient, cost-effective and sensitive method for
exploring the genetics of a complex disorder. Another factor to consider when designing
a study, the analysis of variations in the non-coding region of the genome is mostly
beyond the grasp of current genetic tools available to researchers. Some of the
diseases in which WES has become a common approach include cancer
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221

; autism

222

223

; hereditary myopathy in respiratory failure

syndrome

225

224

; osteogenesis imperfecta and Marfan’s

. The ready availability of relatively inexpensive (compared to whole

genome sequencing) off-the-shelf human exome-capture platforms also aids the entire
process in exploratory studies. Due to homology between the human and other
mammalian genomes (mouse, rat, dogs, cows to name a few), the human kits can also
be used to study the exomes of other species as well.
In this prospective exploratory study, our objective was to explore the canine exome to
identify possible variants that might be associated with LS in a sample cross-sectional
population of MWD Labrador retrievers. Computed tomography imaging was used to
phenotype LS, and genotyping of LS was done by whole exome sequencing using a
commercially available platform (Nextera Rapid Exome Capture kit, Illumina, San Diego,
CA). Additionally, candidate genes from human LSS studies were also investigated to
test whether humans and dogs any of the candidate genes in common with each other.
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IV.2: Materials and Methods
Subjects
Forty Labrador retriever military working dogs (MWDs) were prospectively selected from
the MWD population housed at the US Air Force Base in Lackland AFB San Antonio,
TX. Presence during the time of data collection (from July 8, 2013 to July 13, 2013) was
one of the selection criteria. The other criterion for inclusion in the study, besides the
breed and physical presence, was the age of the dog – the dog had to be between 1
and 5 years of age. Attempts were made to ensure an approximately equal number of
males and females, as well as an approximately equal number of yellow and black
colored dogs. The dogs had to be available for CT scanning and physical examination.
The study had necessary IACUC approval from both the Behavioral Medicine and MWD
Studies Department of US Armed Forces Research Office (Department of Defense
Military Working Dog Veterinary Services or DODMWDVS) and the West Virginia
University Research Office.
Data recorded
All data were collected by a single individual (JJ) with the help of personnel at the
Holland Military Working Dog Hospital (Lackland AFB, San Antonio, TX). The
demographic data collected included dog name and ID number, age, gender,
breeder/vendor (if available) and dog duty status.
After selection for the study, each dog was brought to the military working dog hospital
(within the premises of the Lackland AFB) by the handler to be examined by an
experienced veterinarian for ruling out any medical concerns with sedation. The
veterinarian performed a complete physical examination for each dog and recorded dog
coat color and presence or absence of each of the following clinical signs: reaction to
palpation of the LS junction, reaction to elevation of the tail, or reaction to extension of
the hip joints. The veterinarian interviewed the dog’s handler and other technical staff to
record approximate times the dog spent performing tasks such as jumping up onto or
climbing over obstacles, or assuming an upright stance. Presence or absence of a
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history of reluctance to perform working tasks was also recorded. When available, the
dog’s pedigree was also recorded.
Using a 3cc syringe and either a 22 or 20-gauge needle, blood was drawn from the
cephalic vein of each dog and collected on commercially available sample collection
cards (Whatman™ FTA™ cards, GE Healthcare UK Limited, Buckinghamshire, UK).
Care was taken to ensure that the card was not saturated with blood to reduce the loss
of efficiency during downstream DNA extraction process, also to decrease the time
necessary for complete drying of the blood sample in the initial collection phase. After
the cards were completely dry (approximately one hour as per the manufacturer's
instructions), they were inserted in specially designed and labeled protective pouches
for uncontaminated (both bacterial and fungal) transport of the samples. Care was also
taken to avoid cross contamination between cards. The FTA™ cards were then stored
in airtight boxes at room temperature, in a dry location, and out of direct sunlight to
prevent mold growth and degradation of the genetic material.
Dogs were sedated using the hospital’s standard sedation protocols and the CT
scanner (Lightspeed, GE Medical Systems, Pewaukee, WI) present within the hospital
premises was used to collect trans-axial scans of the lumbar and lumbosacral spine (L4
caudal – S1 cranial vertebrae). The following technical settings were used: axial mode,
0.625 mm slice thickness, 120 kVp, 100 mA, body filter, and bone convolution kernel.
For each scan, dogs were positioned in dorsal recumbency. Scans were acquired with
the rear limbs first placed in a maximally extended position and then repeated with the
rear limbs placed in a maximally flexed position. The hospital’s CT technologist under
the supervision of a licensed veterinarian completed all positioning and scanning
procedures. A standardized protocol for positioning was provided to the technologist to
use as a reference.
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Phenotyping
Qualitative CT phenotyping was done for all 40 dogs in 8 vertebral locations,
encompassing the cranial and caudal ends of 4 lumbar (L4, L5, L6 and L7) and 1 sacral
(S1) vertebra – L4 caudal, L5 cranial, L5 caudal, L6 cranial, L6 caudal, L7 cranial, L7
caudal, and S1 cranial. Using standard criteria for CT radiological diagnosis of LS in
dogs, a single licensed veterinary radiologist (JJ) assigned all 40 dogs to one of two
groups – LS negative or control (no structural stenosis found at any of the 8 locations);
and LS positive or affected (structural stenosis observed in at least in one of the 8
locations). In the previous phenotyping study (chapter III), we found a strong association
between presence of qualitative structural LS and cross-sectional canal FAR (fat area
ratio) values for the 6 vertebral locations analyzed (L5 caudal, L6 cranial, L6 caudal, L7
cranial, L7 caudal, and S1 cranial). So the FAR values were also calculated in this
current study for the quantitative CT phenotyping of LS in these 40 dogs (technique
described in chapter III), but for 8 vertebral locations instead of the original six. Fat area
ratio values for all 40 dogs were then listed in a descending order. The top ten dogs
(highest FAR values = LS negative/control) and the bottom ten dogs (lowest FAR value
= LS positive/affected) were selected for each of the 8 locations. The 4 dogs that
appeared the most number of times (high frequency) in the top ten list across all 8
locations, had the highest FAR values, and were qualitatively LS negative were selected
to represent LS negative (control) dogs in the follow-up genetic analysis. Similarly, the 4
dogs with the highest frequency in the bottom ten list across all 8 locations, lowest FAR
values, and qualitatively LS positive were selected to represent LS positive (affected)
dogs in the genetic study.
Genotyping
Three separate attempts were made to extract genomic DNA from the peripheral blood
collected on commercially available sample collection cards (FTA™, GE Healthcare UK
Limited, Buckinghamshire, UK) and analyzed with 3 different commercially available
DNA extraction kits (using standard manufacturer recommended protocols). First:
Whatman™ FTA™ Purification Reagent (GE Healthcare UK Limited, Buckinghamshire,
UK). Second: Promega Wizard SV Genomic DNA extraction kit (Promega, Madison,
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WI). Third: GenSolve DNA Recovery Kit – GVR-110 (GenTegra LLC., Pleasanton, CA).
The GenSolve protocol was the most successful and included an additional blood
contamination purification step (QIAamp Blood DNA Mini Kit, QIAGEN, Hilden,
Germany). The purified genomic DNA samples were then transported to the Core
Genomics Facility at West Virginia University (Morgantown, WV) for sequencing and
bioinformatic analyses.
Exome sequencing and Bioinformatics
A commercially available exome capture kit (Illumina Nextera Rapid Exome Capture kit,
Illumina Inc., San Diego, CA) was used for exome enrichment and capture, followed by
rapid exome sequencing in the commercially available bench-top sequencer (MiSeq
System, Illumina Inc., San Diego, CA). The personnel at the WVU Genomics Core
Facility (West Virginia University, Morgantown WV) carried out all sequencing reactions
including the library preparations, using manufacturer recommended protocols without
any modifications. Though the kit is designed to capture human exomes there is enough
sequence

homology

between

humans

and

dogs

(Illumina

application

note http://www.illumina.com/products/nextera-rapid-capture-exome-kits.ilmn) to ensure
a successful canine exome capture with a large coverage area. The white paper
published by Illumina claims a success rate of 85% for canine exons with >80%
homology with human exons, while canine exons with <80% homology had a capture
success rate of 18%. The MiSeq sequence data were not recorded (since the
workstation is programmed to automatically map to the human reference genome)
instead the raw files were selected for bioinformatic analysis.
The Genomic Core Facility of West Virginia University also carried out part of the
bioinformatic analysis in this study. The quality of the raw exome reads was analyzed
using FastQC

226

; and Trimmomatic

227

was used to filter out bad reads. The retention

criteria were: leading bases with quality higher than 25, trailing not less than 20, four
base sliding window cutoff of 25 and reads over 50 bases long. Each sample exome
was

then

mapped

to

the

reference

dog

genome

CanFam3.1

CanFam3.1/canFam3 Assembly, September 2011) using Bowtie2
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228

(Broad

(with default

parameters); followed by variant calling using SAMtools
respectively. SnpEff

231

229

and BCFtools

230

,

was used to annotate each called variant, generating a variant

call file (VCF). Another round of annotation was carried out to remove variants not
called in all 8 samples, creating a second VCF file. The genomics core facility provided
this second VCF file to the authors for further analysis (MM). A commercially available
sequence annotation software package (Golden Helix SNP and Variation Suite, Golden
Helix Inc., Bozeman, MT) was used to differentiate between the 4 LS negative dogs and
the 4 LS positive dogs. The VCF file was filtered using the column selection by sample
genotype tool of the software. Two separate selection settings were used to identify
variants between the 2 groups – 4 LS negative or control dogs and 4 LS positive or
affected dogs (with “a” control or reference allele; “b” is the affected or alternate allele;
“a/a” and “b/b” = homozygous for reference and alternate alleles respectively; and “a/b”
is heterozygous). The 1st setting was: control = “a/a”, and affected = “b/b”. And the 2nd
setting was: control = “a/a”, and affected = “a/b” or “b/b”. The 2nd setting was designed
to account for dogs being carriers of the condition (LS) in the heterozygous state.
Exonic variants were identified by aligning the variant list with the canine reference
genome

146

CanFam3.1 (September, 2011 assembly release)

California Santa Cruz (UCSC) genome browser

233 234

232

with the University of

(http://genome.ucsc.edu/cgi-

bin/hgGateway?hgsid=491971977_8JIhYf9FMf1aywMqaevxvSn9eGbg&clade=mammal
&org=Dog&db=0). The list of variants was annotated using a variant effect predictor
web interface (VEP, Ensembl Gene annotation v83, December 2015)

235

. Since not all

canine genes have been characterized, predicted genes were recorded (based on
Ensembl predicted gene sets).

The National Center for Biotechnology Information

(NCBI) Basic Local Alignment Search Tool (BLAST)

236

was used to calculate

percentage homology for the predicted canine gene sequences with the human and
mouse reference gene sequences. The biological significance (i.e. association with
clinical disorders) of the identified genes reported in either NCBI
databases were also recorded.
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237

or Ensembl
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A separate analysis was done to call on any variants previously reported as human LSS
candidate genes – genes associated with other closely related musculoskeletal
diseases like osteoarthritis (OA), Paget’s disease, degenerative disc disease (DDD),
ossification of posterior longitudinal ligament (OPLL), osteogenesis imperfecta (OI) and
Ehlers Danlos syndrome (EDS). The parameters in this second analysis were the same
as the previous analysis – the 4 control dogs were either “a/a” or “a/b”; and the 4
affected dogs were either “a/b” or “b/b”.
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IV.3: Results
Subjects
The 40 Labrador retrievers selected for this study comprised of 20 males and 20
females. Even though we set out to get equal number of black and yellow dogs, the
study ended up with 24 black and 14 yellow dogs, and 1 chocolate colored Labrador
retriever; the remaining single dog’s coat color record was unavailable. The average
body weight of the study population was 28.48 kilograms (range 22.00 – 38.56 pounds).
Based on qualitative phenotyping (CT assessment) by the board-certified radiologist
(JJ), 33 dogs showed signs of structural stenosis in at least one of the eight vertebral
locations and the remaining 7 dogs were free from stenosis in all 8 locations. Sixteen of
the 40 dogs were negative for signs of LBP (in the lumbosacral region) on physical
examination during data collection (CT scanning and blood collection). The remaining
24 dogs did displayed equivocal signs of pain during physical examination. The study
subject demographics are described in Table IV.1.
The 8 dogs selected from aforementioned 40 dogs for whole exome sequencing (WES)
had individuals representing the entire age range of the study i.e. 1 to 5 years. The 4
most LS negative dogs were all females and aged between 1 and 3 years. Three of the
LS negative dogs were related to each other – one dam and two offsprings. The 4 most
LS positive dogs were all males and aged between 3 and 5. There was poor agreement
between LBP status and qualitative assessment of stenosis. Only one out of the 4 LS
negative dogs was negative for signs of LBP, while only two of the 4 LS positive dogs
showed signs of LBP. The demographic data of the 8 dogs selected for WES are
described in Table IV.3.

Phenotyping
The 8 dogs were selected for exome sequencing based on both fat area ratio (FAR)
values as well as qualitative criteria for LS. The maximum and minimum FAR values at
each of the 8 vertebral locations for each of the two groups of 4 (i.e. 4 LS negative and
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4 LS positive dogs) selected to depict the extremes of the phenotype of LS after first
round of selection (but genetic samples lost) are presented in Table IV.2.A. The
maximum and minimum FAR values at each of the 8 vertebral locations for the 8 dogs
selected for exome sequencing to represent the extremes of phenotype after second
round of selection are shown in Table IV.2.B. In the 8 dogs selected in first round, the
smallest FAR values for the LS negative dogs was larger than the highest FAR values
of LS positive dogs at 7 of the 8 vertebral locations. In the 8 dogs from the second
round of selection (whole exome sequencing samples), the lowest FAR values in the LS
negative dogs was also larger than the highest FAR values of the LS positive dogs, but
in 5 of the 8 locations (instead of the 7 in 1st round of selected dogs). Dogs selected in
both rounds as either LS negative or LS positive had agreement with the qualitative CT
diagnosis of LS.

Genotyping
The Nextera Rapid Exome Capture kit requires a minimum concentration of 5-ng/µl
DNA in a final volume of 10-µl (50 ng total). The first method of extracting genomic DNA
from blood on FTA™ cards using FTA™ purification reagent was mostly unsuccessful in
yielding any usable DNA. The second method using Promega Wizard SV Genomic DNA
extraction kit (using standard manufacturer recommended protocol) did yield some
DNA, but the quality was compromised by blood contamination and insufficient quantity
for high resolution downstream sequencing reactions. An unfortunate outcome from this
second method attempt was the loss of samples from the 8 dogs that best met the
selection criteria. A second round of phenotyping selection was done to get the next
best 8 dogs (4 LS negative and 4 LS positive) that also met the selection criteria. The
third method using GenSolve DNA Recovery kit had the best performance of the 3
methods at yielding DNA of sufficient quality and quantity needed for sequencing
reactions. The genomic DNA yield from this method (for all 8 samples) ranged between
11.9 and 13.2 ng/µl suspended in a final solution volume of 100 µl AE buffer (QIAGEN,
Hilden, Germany) – thus more than meeting the minimum requirements of the exome
capture kit used (Illumina’s Nextera Rapid Exome Capture kit).
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Exome Sequencing and Bioinformatics
The sequencing runs for all 8 dogs (4 LS negative and 4 LS positive) resulted in fairly
even representation among samples. After eliminating poor-quality raw exome reads,
alignment with the reference canine genome (Broad CanFam3.1/canFam3 Assembly,
September 2011) gave a good alignment value (95+%). The VCF file provided by the
Genomics Core Facility included 110, 980 variants (variants called in all 8 samples). Out
of these 110,980 variants, 439 had to be excluded because they could not be assigned
to any known canine chromosome number. Golden Helix SVS was used to analyze the
remaining 110,541 variants. No exonic variants matching the 1st sample genotype
setting i.e. LS negative (“a/a”) vs. LS positive (“b/b”). The 2nd sample genotype setting
detected 252 variants, i.e. LS negative dogs (“a/a”) vs. LS positive (“a/b” or “b/b”).
Manual curation identified 82 exonic variants (out of 252). These 82 exonic variants
encompassed a total of 33 genes (both annotated and predicted) and the data are
represented in Table IV.4. The predicted genes along with their percentage homology
with the orthologous human and mouse genes are reported in Table IV.5. The list of 252
variants was also annotated using VEP tool of Ensembl. Twenty-three of the 252
variants did not parse by VEP so could not be analyzed. Out of the 229 variants
analyzed, 165 (72.1%) were novel. All possible consequences of the 229 analyzed
variants are summarized in Figure IV.1. Out of all the variants detected that were
present in coding regions, majority (80%) were synonymous mutations, and the
remaining 20% were missense mutations as depicted in Figure IV.2. VEP was unable to
identify any high impact variants (disruptive like protein truncation, loss-of-function or
triggering nonsense mediated protein decay); but it was able to identify some moderate
impact variants (non-disruptive that might change protein effectiveness) encompassing
10 genes (both annotated and predicted). The variants detected by VEP and assigned
as having moderate impact are listed in Table IV.6.. Since not all canine genes have
been annotated yet, there are some genes in the list with no known gene symbol,
however the genome location was used to match the missing variants with the list
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generated manually. The VEP was also able to identify several low impact variants
(assumed to be mostly harmless and/or unlikely to influence protein behavior) spanning
a total of 24 genes (also identified by manual curation, see Table IV.5). Thus VEP was
able to identify one more gene (10 + 24 = 34) than the list of genes identified manually
(33). Impact assessment was not possible in the manual method.
Functions and biological significances (previously reported associations with clinical
syndromes) of the 33 genes that contain the 82 exonic variants (and matches the
sample genotype parameters) are reported in Table IV.7. Of the 10 genes with variants
having moderate impact (as identified by VEP), one gene could possibly have an
association with LS in Labrador retrievers – Transthyretin (TTR). A missense mutation
(preserved protein length but with a different amino acid) was detected in TTR gene.
Recent studies have reported that TTR-derived amyloidosis might have an association
with Senile Systemic Amyloidosis (SSA) in humans

239

, a condition where amyloid

protein deposits can be found on musculoskeletal connective tissues, usually also
accompanied by LSS (lumbar spinal stenosis) and cardiomyopathy. Among the 24
genes identified by VEP as having variants with low impact, two genes could also have
some association with LS in Labrador retrievers: Folate Receptor 2 (FOLR2), and
Ubiquitin Specific Peptidase 9 X-linked (USP9X). Folate Receptor 2 or beta has been
known to be associated with osteoarthritis (OA)

240

, and association between OA and

LSS in humans is well documented. USP9X is an X-linked gene that escapes Xinactivation in mammalian females

241

, so females contain twice the dose of this gene

product as males. The sex-specific trend of LS in dogs (males are affected almost twice
as females, according to some reports) could mean that LS is an X-linked condition, and
USP9X gene product doses being different between males and females could be
playing a role in LS disease pathology. The positions of the candidate genes (from
human LSS studies) in the canine genome (Broad CanFam3.1/canFam3 Assembly,
September 2011) are represented in Table IV.8. No exonic variants were detected in
any of the human LSS candidate genes.
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IV.4: Discussion/Conclusion
To the best of our knowledge, this is the only study that has investigated the genetics of
lumbosacral stenosis (LS) in Labrador retrievers. Lumbosacral stenosis is the most
common lumbosacral spinal disease affecting large breed dogs like German shepherds
and Labrador retrievers. Even though German shepherds is the breed in which LS has
been reported the most, most of these studies have also reported the Labrador
retrievers as another affected breed (often as a close second according to recorded
frequencies). There are several studies that have focused on LS in German shepherds,
but as far as we know no other group is actively studying LS in Labrador retrievers –
another high-risk breed for LS. And with respect to genetic association studies of LS in
dogs, none have been reported in any breed (as of the time of this manuscript
preparation). Since LS is a naturally occurring disease in both Labrador retrievers and
German shepherds, either of the 2 breeds could be a viable model for canine LS, but
the growing popularity and vast numbers of Labrador retrievers found in the United
States, not only as household pets but also as working dogs (especially detection
military working dogs or MWDs), makes Labrador retrievers a popular choice for LS
studies.
To make the most of the whole exome sequencing (WES) study, the first strategy is to
select the optimum study subjects – usually ones representing the extremes of the
phenotype being investigated
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. With this approach, even a low number of study

subjects can yield usable data. Military working dogs are selected and trained to be
high-performance athletes. There exists a theory in human medicine that a physically
strenuous and active life (like that led by athletes) can result in premature degeneration
of the musculoskeletal system, which in turn can lead to early appearance of
degenerative diseases – like LS. However there is little scientific evidence to back this
statement. A similar theory also exists in canine medicine – and again there is a lack of
scientific evidence to support it. Future studies investigating the effects of strenuous
exercise on phenotypic expression of degenerative LS are needed in both human and
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canine athletes. Military working dogs would be a desirable study population for this
research. In the current study, advantages of using MWD Labrador retrievers from a
single military base (Lackland AFB, TX) as the study subjects were: (i) all dogs in the
study were present at the same physical location making the logistics of data collection
simple; (iii) all the dogs had a highly uniform lifestyle – same diet, same exercise
regimen, same healthcare opportunities (Holland Military Working Dog Hospital present
inside the military base premises), same living conditions, and all dogs are maintained
at a high level of physical fitness ensuring – thereby ruling out several possible sources
of external environmental variation that might have influenced the genetic association
results; and (iii) the availability of the in-house CT scanner made the acquiring of CT
scans for the phenotyping part of the study a much more feasible process.
Disadvantages of using this sample population were that results might not be
generalizable for other breeds and other types of work. Another limitation of this
population is the absence of pedigree records for majority of the dogs due to
procurement from a variety of vendors. This particular method of acquiring MWDs is
common. In future studies more pro-active methods of selection of MWDs would be
desirable.
However, the presence of the study subjects inside a secure military base also led to
the logistical problem – DNA could not be isolated on-site, samples had to be collected
on site and then safely transported with viable DNA for genetic analysis at a later date.
Even though fresh blood in EDTA gives the best DNA yield, transportation would have
posed a problem, and the samples would have to be processed as soon as possible
(blood in EDTA does not have a long shelf life with or without refrigeration). Therein
came the advantage of using Whatman™ FTA™ (Flinders Technology Associate) cards
– a relatively inexpensive medium for collecting biological samples (saliva, cell cultures,
plant extracts, blood etc.), that can be stored for extended periods of time (sometimes
up to decades), while preserving the genetic material for future genetic analyses
(protected from external factors like environment and microbial contamination). The
amount of blood required for analysis is also small compared to other comparable
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methods (blood in EDTA tubes). FTA™ cards are common practice in collecting genetic
material in agricultural settings, including plants and animals like cows (Hu, 2010 #680),
horses

243

, and dogs

244

– especially in situations where in field laboratory setup is

unavailable, or there is need for transportation and storage of samples without
refrigeration. This feature of FTA™ cards allowed us to extract viable DNA (sufficient
quality and quantity for sequencing study) 2 years after data collection – samples were
collected in 2013, and DNA was extracted in 2015). So FTA™ cards can be a viable
method for collection of genetic material from MWDs, especially because of the
unpredictability of their location at any given point of time. In fact, FTA™ cards have
already been in use in the US military for collecting DNA from human soldiers (for
identification purposes). FTA™ cards can easily transition to benefit the health and
welfare of the canine soldiers by collecting their genetic material not only for
identification purposes but also for medical testing. We do acknowledge the fact that
the amount of DNA extractable from these cards is not as high as one might get from
fresh blood in EDTA tubes or buccal swabs (standard practices in canine genetic
research), but situations in which transport and storage of the genetic material are of
concern, FTA™ cards could be the solution. FTA™ cards could also provide a unique
opportunity to perform longitudinal studies.
The Yao lab at WVU already uses the Promega Wizard SV Genomic DNA recovery kit
for DNA extractions needed for their ongoing projects in aquaculture and reproductive
physiology. The ready availability of this kit inspired the attempt of extracting DNA from
FTA™ cards using this method. The DNA yield was decent (average yield of 25
nanogram per microliter in 50 microliters suspension), but the blood contamination was
also quite high (often visible as a reddish hue in solution). We attempted to purify the
DNA with ethanol purification and DNA purification kits, but that resulted in loss of
usable DNA volume. So we propose that the Promega kit can be used to extract DNA
for basic PCR reactions but if the end-goal is sensitive sequencing reactions, then
Promega Wizard SV Genomic DNA Recovery kit is probably not the best approach for
DNA isolation from blood spots on FTA™ cards, without running an additional
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purification step to remove blood contaminants. GenTegra GenSolve kit gave us better
yield of DNA from blood on FTA™ cards. However, a major limitation of this study was
the loss of DNA from the best 8 candidate dogs during initial DNA isolation phase. It
would be beneficial to do a follow-up study in a larger population of true LS negative
and LS positive Labrador retrievers to test the validity of FTA cards as a workable
medium for collection of canine genetic material and GenTegra GenSolve kit’s ability to
extract the canine genetic material out of the FTA cards.
The 40 dogs in the study comprised of equal number of males and females, and the LS
positive group was made up of 17 males and 16 females. Selection of dogs for exome
sequencing to represent the extremes of the phenotype (LS positive or LS negative)
was blinded. The dogs selected comprised of 4 affected males (LS positive) and 4
unaffected females (LS negative). This all male and all female selection was
coincidental. Previous human LSS and canine LS studies have reported a higher
incidence in males than in females. Possible reasons suggested include faster growth
rate of males, larger body weight and more popular choice as working dogs
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. It is important to note that 3 of the LS negative dogs were related to each other and

this could be a possible source of bias in the results. Complete pedigree information for
all 40 dogs in the study was not available, so pedigree analysis was not possible. A
future study investigating the pedigree structure of these dogs could yield valuable
insight into prevalence of LS within the MWD population.
Low back pain (recorded as part of the physical examination during data collection) and
LS status (recorded based on veterinary radiologist diagnosis) of the dogs included in
this study did not agree consistently. This was in agreement with previous reports in
MWDs

187 16

. Only 1 of the 7 LS negative dogs (14.3%) was LBP negative, the other 6

(85.7%) showed signs of pain despite being negative for stenosis (according to CT
findings). Of the 33 dogs that were designated LS positive (in at least one vertebral
location), 18 dogs (54.5%) were LBP positive, however there were 15 dogs (45.5%) that
showed no signs of LBP despite being positive for LS. One possible explanation for this
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discrepancy could be the fact that these dogs are selected and bred for stoicism and
high working drive. Therefore some dogs with LS could have been masking their clinical
signs. Another possible reason for the discrepancy could be that LBP might have been
caused by other clinical problems besides LS like degenerative sacroiliac joint disease
(DSJD)

132

, foraminal stenosis

133

and Schmorl’s nodes

134

. This high-drive personality

makes this breed an excellent candidate for working dogs, but can also be
disadvantageous in early detection of LS based on signs of LBP alone since the same
trait that makes them good working dogs, also makes them good maskers of pain.
Age is usually considered to be a factor in degenerative LS, however in this study as a
whole constituted of only young dogs, both groups (LS negative and LS positive) had
representation from all ages (1 to 5). The appearance of LS at such relatively young
ages could signal a different etiology of LS in this population of dogs i.e. MWDs. Since
these dogs are too young to acquire degenerative changes in their bodies (despite the
nature of their lifestyle), the type of LS affecting these MWDs could be idiopathic.
The FAR values in all LS negative dogs were consistently higher than the FAR values in
LS positive dogs. The minimum FAR values for the LS negative group for 5 of the 8
locations were higher than the maximum FAR values in the LS positive group (L5
cranial and caudal; L6 cranial; L7 cranial and caudal). This further supports the results
from previous study (chapter III) – that fat area ratio (FAR) is a viable tool to
quantitatively phenotype LS in Labrador retrievers. Studies need to be conducted to test
the validity of FAR as a measure of LS not only in a larger sample of Labrador
retrievers, but also in other breeds of dogs and maybe in humans as well.
Even though WES usually involves small sample size, our sample size of eight
individuals was too small to allow robust statistical analyses. Future studies with larger
sample sizes are needed that would increase the power of statistical analyses. Also at
the time this study was planned and conducted, there was no dedicated canine exome
capture platform available in the market. However, since then an exome capture kit
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specific to the canine genome has been developed (Roche NimbleGen, Madison, WI).
Future analyses using this species-specific kit would be desirable to improve the
sensitivity of future canine WES studies in identifying genetic variants underlying LS.
Out of all the variants identified between the control and affected groups from the
exome sequencing data, only 252 variants met the criteria that accounted for either
asymptomatic or carriers. The study was unable to find any variants where the
relationship between variants and phenotype was more straightforward without the need
for making allowance for carriers/asymptomatic samples. Variant Effect Predictor was
unable to find any variants with high impact and it could not annotate all the variants to
specific predicted genes. VEP was able to identify variants with moderate impact (10
genes) and low impact (24 genes). Manual curating of the VCF file using Golden Helix
SVS software was able to assign 82 of the 252 variants to exons of 33 protein-coding
genes (NCBI and Ensembl). Of the 33 genes, 3 genes could have possible associations
with LS in Labrador retrievers – Transthyretin (TTR), Folate Receptor 2 (FOLR2) and
Ubiquitin Specific Peptidase 9, X-linked (USP9X).
First, TTR – recent studies have reported that TTR-derived amyloidosis might have an
association with SSA (senile systemic amyloidosis) – a group of disorders involving the
localized deposition of amyloid proteins in a variety of tissues 246. A 2011 study found an
association between senile systemic amyloidosis and lumbar spinal stenosis in the
Japanese population

247

. This study examined ligamentum flavum specimens from 36

individuals with confirmed cases of LSS. Nineteen of the 36 samples tested positive for
amyloid protein deposits. There are at least 30 different types of amyloid proteins that
can be deposited in the human body

248

. Transthyretin-derived amyloidosis (ATTR) is

one such condition and 16 of those 19 specimens with SSA that tested positive for
amyloid deposits, had ATTR. Another recent study has also found an association
between transthyretin-derived amyloidosis in SSA and LSS within the Swedish
population

239

. This study comprised of resected material (bone fragments, pieces of

ligament and other connective tissues) from 26 patients undergoing surgery for lumbar
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spinal stenosis (the only inclusion criterion). Amyloid deposits were detected in 25 of the
26 samples. Deposits of amyloid protein in the brain have been well investigated for
several years because of the role it plays in Alzheimer’s disease and Down’s syndrome
249

. Amyloid deposits are also commonly found in connective tissues like ligaments,

tendons and cartilages especially in the joints (knee, hip, vertebrae) of elderly
individuals
unknown
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239

; but the biological significance of this type of amyloidosis is

. Similar to the amyloidosis seen in Alzheimer’s disease (brain tissue),

ATTR deposits (connective tissue/skeletal tissue/neural tissue) are also believed to be
aging-related and are usually observed in individuals older than 60 years of age.
Transthyretin-derived amyloidosis has a higher rate of incidence in males when
compared to females; and is usually accompanied by cardiomyopathy and carpal tunnel
syndrome as clinical complications. All these factors imply that LSS could be a
consequence of SSA, making the transthyretin (TTR) gene a good candidate gene for
future studies of LSS in humans, and maybe TTR could also be associated with LS in
Labrador retrievers. Second, FOLR2 has been found in macrophages present in the
synovial fluid of patients suffering from osteoarthritis (OA)

240

. And lastly, USP9X is an

X-linked gene that escapes X-inactivation in mammalian females

241

, so females have

twice the dose of this gene product as males. The sex-specific trend of LS in dogs
(males are affected almost twice as females, according to some reports) could mean
that LS is an X-linked condition, and USP9X gene product could be playing a protective
role in LS disease pathology, and is the cause for the difference in incidence rate
observed between males and females Despite these findings, it is important to note that
these are just conjectures at this point, future studies investigating these “new candidate
genes”, especially TTR, are needed to delineate the true relationship between these 3
genes and LS in Labrador retrievers.
Another important aspect of the results in this study was the absence of any exonic
variants within human LSS candidate genes. The sample size of this study was too low
to rule out the involvement of these human LSS candidate genes altogether, so further
analyses are needed in a larger sample size of Labrador retrievers to investigate the
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true relationship between canine LS and human LSS candidate genes. Also the genetic
findings in this study could be specific for idiopathic LS and not degenerative LS. The
candidate genes from human LSS studies (mostly degenerative kind) could be shared
by degenerative type of canine LS.
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Figure	
  IV.1.	
  

Figure IV.1. Consequences of 229 variants analyzed by Ensembl’s Variant Effect
Predictor
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Figure	
  IV.2.	
  

Figure IV.2. Percentage breakdown of variants with coding regions based on type of
mutation
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Table IV.1. Clinical data demography of the study samples

Group

CT LS negative

CT LS positive

Number

7

33

Average Age

2.57 (± 0.45)

2.88 (± 0.22)

Sex

3 M, 4 F

17 M, 16 F

Average Weight

25.80 (± 1.35)

29.05 (± 0.72)

Weight Range

22.50 - 32.66

22.00 - 38.56

Low back pain (LBP) status

6 positive, 1 negative

18 positive, 15 negative

Legend:
CT – computed tomography

LS – lumbosacral stenosis

M – male

F – female

W – working

NW – non-working

74

Table IV.2.A. Maximum and minimum fat area ratio values for 8 vertebral locations
among the 8 dogs selected to represent the extremes of the phenotype – 1st
round of selection (samples lost)

Vertebral location

LS negative

LS positive

Max

Min

Max

Min

L4Cd

0.174

0.113

0.115

0.029

L5Cr ^

0.183

0.075

0.061

0.028

L5Cd ^

0.307

0.218

0.155

0.088

L6Cr ^

0.169

0.148

0.120

0.058

L6Cd ^

0.373

0.297

0.202

0.140

L7Cr ^

0.205

0.128

0.109

0.065

L7Cd ^

0.379

0.294

0.230

0.199

S1Cr ^

0.195

0.144

0.091

0.044

Table IV.2.A. Maximum and minimum Fat Area Ratio (FAR) values for all of the 8
vertebral locations within the 2 groups of 4 dogs each (LS negative and LS positive).
^ Denotes vertebral locations where the lowest FAR value in LS negative (control) dog
group was greater than the highest FAR value in LS positive (affected) dog group.
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Table IV.2.B. Maximum and minimum fat area ratio values for 8 vertebral locations
among the 8 dogs selected to represent extremes of the phenotype – 2nd round of
selection (whole exome sequenced samples)

Vertebral location

LS negative

LS positive

Max

Min

Max

Min

L4Cd

0.115

0.074

0.099

0.038

L5Cr ^

0.140

0.088

0.056

0.029

L5Cd ^

0.268

0.215

0.162

0.099

L6Cr ^

0.162

0.143

0.089

0.067

L6Cd

0.294

0.233

0.251

0.189

L7Cr ^

0.162

0.142

0.091

0.052

L7Cd ^

0.338

0.264

0.262

0.207

S1Cr

0.173

0.136

0.166

0.077

Table IV.2.B. Maximum and minimum Fat Area Ratio (FAR) values for all of the 8
vertebral locations within the 2 groups of 4 dogs each (LS negative and LS positive).
^ Denotes vertebral locations where the lowest FAR value in LS negative (control) dog
group was greater than the highest FAR value in LS positive (affected) dog group.
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Table IV.3. Demographic data of the 8 dogs selected for exome sequencing

Characteristic

LS negative

LS positive

Age

1, 1, 2, 3

3, 4, 4, 5

Sex

4F

4M

Mean weight

24.05

31.75

LBP status

3 Y, 1 N

2 Y, 2 N

Coat color

3 BL, 1 YL

3 BL, 1 YL

Work status

2 BR, 2 IT*

2 IT, 1 TA, 1 HH^

* - Former breeders (BR) that were spayed and placed in training (IT)
^ - Detection dog but put in hospital hold for T. cruzi infection
Legend:

Breeder

BR

Female F

In-training

IT

Male

M

Training aide

TA

Yes

Y

Hospital hold

HH

No

N

Black

BL

Yellow

YL
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Table IV.4. List of single nucleotide variants present within the canine exome and
the genes that the exons correspond to as detected by manual curating

Single nucleotide variants within exons
Chromosome

Gene

Control

Affected

Number

number

Position

symbol

sequence

sequence

1

1

89360055

DOCK8

T

C

2

1

118921713

SLC7A10

C

T

3

1

119322126

RGS9BP

C(G)

T(A)

4

1

120453353

TSHZ3

C

T

5

4

20145950

KIF1BP

G

A

6

6

9069346

TFR2

C

T

7

7

2203010

KIF21B

C

T

8

7

10364384

DTL

G

A

9

7

56104696

ASXL3

T(A)

C(G)

10

7

56104802

ASXL3

G(C)

T(A)

11

7

56106097

ASXL3

C(G)

T(A)

12

7

57689546

TRAPPC8

C

T

13

7

57946958

TTR

T(A)

C(G)

14

8

4065167

LRRC16B

G

A

15

8

50655038

ADCK1

C

T

16

10

69081780

ADD2

C(G)

T(A)

17

11

24735565

SPOCK1

G (C)

A(T)

18

13

22573204

RNF139

A

G

19

13

22573204

TATDN1

A(T)

G(C )

20

14

26883347

EEF1A1

G

A

21

14

26883912

EEF1A1

G

A

22

14

31311638

AGR2

G(C )

A(T)

23

14

36176692

DNAJA1

A(T)

G(C )

24

14

36176713

DNAJA1

A(T)

G(C )

25

14

52320547

TMEM168

G(C )

A(T)

26

15

61421904

CPE

T

G

27

17

8320429

GREB1

A

G

28

20

39606726

BSN

C(G)

T(A)
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29

20

39607968

BSN

G(C )

A(T)

30

20

45454325

ABHD8

T

C

31

21

25954898

FOLR2

T(A)

C(G)

32

25

19512970

PALLD

T

C

33

25

19513039

PALLD

C

T

34

27

25335426

ABCC9

C

T

35

27

31190558

PTPRO

T(A)

C(G)

36

32

17161549

SMARCAD1

T

A

37

34

32184660

ZBBX

A(T)

T(A)

38

34

32184727

ZBBX

T(A)

C(G)

39

X

19788051

ZFX

A

C

40

X

19788059

ZFX

C

A

41

X

19788111

ZFX

C

T

42

X

19788144

ZFX

G

A

43

X

19789071

ZFX

G

A

44

X

19789132

ZFX

A

T

45

X

19789173

ZFX

C

A

46

X

19789176

ZFX

C

T

47

X

19789317

ZFX

A

G

48

X

19789321

ZFX

G

A

49

X

19789401

ZFX

C

T

50

X

19789437

ZFX

C

T

51

X

19789440

ZFX

C

T

52

X

19789458

ZFX

A

G

53

X

19789494

ZFX

G

C

54

X

19789503

ZFX

G

A

55

X

19789515

ZFX

G

A

56

X

19789551

ZFX

G

A

57

X

19789563

ZFX

A

G

58

X

19789569

ZFX

T

C

59

X

19789651

ZFX

C

G

60

X

19789653

ZFX

T

C

61

X

19789689

ZFX

C

T

62

X

19789692

ZFX

C

T

63

X

19789716

ZFX

T

C
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64

X

19789740

ZFX

G

A

65

X

19789749

ZFX

G

A

66

X

19789803

ZFX

T

C

67

X

19789818

ZFX

C

T

68

X

19789839

ZFX

A

G

69

X

19789906

ZFX

C

T

70

X

19789908

ZFX

C

G

71

X

19789914

ZFX

C

T

72

X

19790001

ZFX

C

T

73

X

19790028

ZFX

G

A

74

X

19790031

ZFX

C

T

75

X

19790040

ZFX

T

C

76

X

19790091

ZFX

A

G

77

X

19790106

ZFX

C

T

78

X

19790136

ZFX

T

G

79

X

19790197

ZFX

C

T

80

X

19790207

ZFX

A

G

81

X

35651733

USP9X

G (C)

A (T)

82

X

35659594

USP9X

G (C)

A (T)

Table IV.4. List of 82 exonic variants matching sample genotype parameters (as
detected by manual curation)
Also listed are the positions of the variants in the canine genome, the gene symbols
they correspond to, and the sequence variation. Instances where the gene is read in the
reverse, parentheses were used to denote the sequence of the sense strand and the
sequence outside of the parentheses the sequence of the reverse strand. The 82 exonic
variants encompass a total of 33 genes.
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Table IV.5. List of canine genes with exonic single nucleotide variants and their
percentage homology with human and mouse orthologues

Dog (Canis familiaris)

Human (Homo sapiens)

Mouse (Mus musculus)

Chr.

Ensembl predicted gene

Chr.

Sequence

Chr.

Sequence

No.

name

No.

identity (%)

No.

identity (%)

1

1

DOCK8

9

93

2 e^-90

19

88

2 e^-70

2

1

SLC7A10

19

93

1 e^-74

7

91

1 e^-69

3

1

RGS9BP*

19

81

1 e^-167

7

76

4 e^-98

4

1

TSHZ3

19

91

0

7

87

0

5

4

KIAA1279 a.k.a. KIF1BP

10

88

0

10

81

0

6

6

TFR2

7

88

5 e^-52

5

87

4 e^-37

7

7

KIF21B

1

76

2 e^-173

1

91

7 e^-79

8

7

DTL

1

92

0

1

85

0

9

7

ASXL3*

18

87

0

18

81

0

10

7

TRAPPC8

18

90

0

18

81

0

11

7

TTR*

18

94

4 e^-24

18

NA

NA

12

8

LRRC16B*

14

90

3 e^-109

14

89

8 e^-109

13

8

ADCK1

14

93

1 e^-75

12

92

2 e^-74

14

10

ADD2 a.k.a. ADDB

2

84

3 e^-133

6

93

6 e^-55

15

11

SPOCK1

5

91

2 e^-139

13

90

3 e^-72

16

13

RNF139

8

92

0

15

91

0

17

13

TATDN1

8

86

1 e^-48

15

88

0

18

14

EEF1A1**

6

88

0

9

86

0

19

14

AGR2

7

85

2 e^-32

12

92

3 e^-19

20

14

DNAJA1**

9

89

0

4

89

0

21

14

TMEM168

7

81

0

6

88

0

22

15

CPE

4

82

0

9

88

3 e^-6

23

17

GREB1 or KIAA0575

2

86

0

12

79

3 e^-109

24

20

BSN or ZNF231

3

88

0

9

84

0

25

20

ABHD8

19

87

0

8

90

2 e^-53

26

21

FOLR2 or FBP

11

94

1 e^-73

7

81

2 e^-26

27

25

PALLD

4

84

0

8

80

3 e^-86

28

27

ABCC9

12

95

5 e^-100

6

86

2 e^-64

No.

81

E-value

E-value

29

27

PTPRO*

12

78

0

6

91

2 e^-41

30

32

SMARCAD1

4

92

0

6

82

0

31

34

ZBBX*

3

84

2 e^-78

3

80

2 e^-42

32

X

ZFX**

X

91

0

X

85

0

33

X

USP9X

X

93

0

X

86

0

Table IV.5. List of 33 genes with exonic variants between LS negative (control) and LS
positive (affected) Labrador retrievers
Also listed are the percentage homology between the predicted genes (according to
Ensembl database) and the human and mouse orthologues
* – Genes annotated by VEP as carrying moderate impact variants
** – Genes identified by VEP as carrying moderate impact variants but not annotated
due to the uncharacterized nature of the canine gene product
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Table IV.6. Variants with moderate impact as detected by Ensembl’s Variant Effect
Predictor (VEP)

Location

Variant
allele

Symbol

Gene

Exon

Amino
acid

Codons

Strand

1:117510670

T

SCN1B

ENSCAFG00000007129

1/5

A/T

Gca/Aca

-1

1:119322126

T

RGS9BP

ENSCAFG00000007509

1/1

R/H

cGc/cAc

-1

7:56104802

T

ASXL3

ENSCAFG00000017980

10/11

T/N

aCt/aAt

-1

7:56104802

T

ASXL3

ENSCAFG00000017980

4/5

T/N

aCt/aAt

-1

7:57946958

C

TTR

ENSCAFG00000018046

1/4

S/G

Agc/Ggc

-1

8:4065167

A

LRRC16B

ENSCAFG00000011712

16/40

A/T

Gcc/Acc

1

14:26883912

A

-

ENSCAFG00000009915

4/8

A/T

Gcc/Acc

1

14:36176692

C

-

ENSCAFG00000009635

4/6

W/R

Tgg/Cgg

1

14:36176713

C

-

ENSCAFG00000009635

5/6

C/R

Tgt/Cgt

1

27:31190558

C

PTPRO

ENSCAFG00000012789

2/27

N/S

aAc/aGc

-1

34:32184727

C

ZBBX

ENSCAFG00000014517

18/20

K/R

aAa/aGa

-1

34:32184727

C

ZBBX

ENSCAFG00000014517

16/17

K/R

aAa/aGa

-1

X:19788059

A

-

ENSCAFG00000013408

6/7

T/N

aCc/aAc

1

X:19789132

T

-

ENSCAFG00000013408

7/7

T/S

Acc/Tcc

1

X:19789321

A

-

ENSCAFG00000013408

7/7

A/T

Gcc/Acc

1

X:19789651

G

-

ENSCAFG00000013408

7/7

L/V

Ctt/Gtt

1

X:19789906

T

-

ENSCAFG00000013408

7/7

L/F

Ctc/Ttc

1

Table IV.6. List of moderate impact variants detected by VEP (i.e. non-disruptive
capable of changing protein effectiveness)
Also listed are the chromosome number, position, variant allele, name and annotation of
the gene that the exon is part of and the amino acid change that takes place due to the
variant. Variants without gene symbol represent canine genes that have yet to be
characterized.
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Table IV.7. Biological significance and function of the 33 genes with detected
exonic variants
#

Chr

Predicted

Conserved

#

gene

species

Description

Chimps,
Rhesus
1

1

DOCK8

Monkey, Cow,
Chicken, Frog,

Dedicator

of

cytokinesis 8

Rat, Zebrafish

2

1

SLC7A10

Biological

Function

Chimps, Frog

Solute carrier

Chicken, Rat,

family

Zebrafish

member 10

7

significance

Encodes a member of DOCK180

Autosomal

family

recessive

guanine

nucleotide

exchange factors that interact

form

with Rho GTPases & take part in

hyper-IgE

intracellular signalling networks.

syndrome

Asc-type amino acid transporter Mediates high-affinity transport of

Visceral fat in

D-seine and several other neutral

women

amino acids
Encodes protein that regulates G

3

1

RGS9BP

Chimps,

Regulator

Rhesus

G

Monkey, Cow,

signaling

Frog Chicken,

binding

the protein to be expressed only

Rat, Zebrafish,

protein

in the retina (rod outer segment

of

protein
9

protein-coupled

receptor

signaling in photo-transduction.
Bovine and mouse studies show

membranes)
Chimps,
Rhesus
4

1

TSHZ3

Monkey, Cow,
Rat, Chicken,
Zebrafish,

Teashirt zinc
finger
homeobox 3

Frog

Bradyopsia
(prolonged
electro-retinal
response
suppression
or PERRS)

Methylation of TSHZ3 promoter is

Breast

present

Prostrate

in

breast/prostrate

4

Rhesus

KIF1 (kinesin

KIAA1279

Monkey, Cow,

family

a.k.a.

Rat, Chicken,

member

KIF1BP

Zebrafish,

binding

Frog, Fruit fly,

protein

1)

cancer, Pelvi-

differentiation in the ureter in

ureteric

conjunction

junction

with

SOX9

and

MYOCD

obstruction

Encodes protein that localizes to

Goldberg-

the

maybe

Shprintzen

regulating

megacolon

mitochondria

involved

and

in

mitochondrial transport

Mosquito
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&

cancer. Regulation of myogenic

Chimps,

5

of

syndrome

Single-pass type II membrane
protein (member of transferrin
Chimps,
6

6

TFR2

receptor-like family) that mediates

Rhesus

Transferrin

cellular

Monkey, Cow,

receptor 2

bound

Rat, Zebrafish

uptake

of

transferrin-

iron

(iron

metabolism/hepatocyte

Hereditary
hemochromat
osis type III

function/erythrocyte
differentiation)
Encodes
Chimps,
7

7

KIF21B

Rat,

Frog Chicken,
Zebrafish

Kinesin family
member 21B

member

superfamily

of

kinesin

(ATP-dependent

Inflammatory
bowel

microtubule-based motor proteins

disease

involved in intracellular transport

Multiple

of membranous organelles)

sclerosis
Cancers
ovarian,

Chimps,

8

7

DTL

-

Rhesus

Denticleless

Monkey, Cow,

E3

Rat, Chicken,

protein ligase

Zebrafish,

homolog

ubiquitin

colon,
Involved in stress-related DNA

gastric,

damage

breast, liver,

repair

and

ubiquitin-

protein

throat,
osteosarcom

Frog

a,

Ewing

sarcoma

9

7

ASXL3

Chimps,

Additional sex

Rhesus

combs

Monkey, Cow,

transcriptional

Chicken, Frog

regulator 3

like

Both
Belongs to family of epigenetic
scaffold proteins

cancerous
and

cancerous
diseases

Chimps,
Rhesus

10

7

TRAPPC8

Monkey, Cow,

Trafficking

Rat, Chicken,

protein

Involved in various stages of

Zebrafish,

particle

vesicle transport

Frog, Rice A.

complex 8

thaliana, Fruit
fly, Mosquito
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non-

NA

Amyloidotic
polyneuropat
hy, euthyroid
hyperthyroxin
aemia,
One of the 3 prealbumin carrier
proteins that transport thyroid
hormones in the plasma and
CSF, also retinol in plasma. Also

Chimps,

found

Rhesus
11

7

TTR

Monkey, Cow,
Rat, Chicken,

on

cartilage

surfaces

(extracellular
Transthyretin

organization).
mutations

Zebrafish,

related

Frog

matrix

to

disorders

More

reported

than
-
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mostly

amyloid

deposition

affecting

peripheral

nerves and/or heart.Associated
with aging (loss over time) leads
to Alzheimers. Neuropeptide Y

amyloidotic
vitreous
opacities,
cardiomyopat
hy,
oculoleptome
ningeal
amyloidosis,
meningocere
brovascular
amyloidosis,
carpal tunnel
syndrome,
Leiden
muscular
dystrophy,
osteoarthritis
and

spinal

stenosis
Chimps,

12

8

LRRC16B

Candidate
rich

in

gene

Rhesus

Leucine

Monkey, Cow,

repeat

that should get down-regulated/

Rat, Chicken,

containing

undetectable in adult tissue, but

Zebrafish,

16B

are found in tumors). Also in

Frog

(expressed

onco-fetal

embryos/fetuses

mammalian neurogenesis.

86

Cancer

Chimps,
Rhesus
Monkey, Cow,
Rat, Chicken,
Zebrafish,
13

8

ADCK1

Frog, Fruit fly,

aarF domain

Mosquito,

A.

containing

thaliana,

C.

kinase 1

elegans,

S.

Function unknown.

NA

cerevisiae, S.
pombe,

M.

oryzae,

N.

crassa, Rice

14

10

ADD2

a.k.a.

ADDB

Chimps,

Encodes for beta subunit of the

Rhesus

adducin family that cross-links

Monkey, Cow,

actin filaments with spectrin at

Rat, Chicken,

found in brain and hematopoietic

Frog

cells.

Rhesus
11

SPOCK1

Monkey, Cow,
Rat, Chicken,
Zebrafish

16

13

RNF139

cytoskeletal membrane. Primarily

Zebrafish,

Chimps,
15

Adducin 2

Sparc/osteon
ectin,

cwcv

and kazal-like
domains
proteoglycan
(testican) 1

plasma proteoglycan containing
chondroitin and heparan-sulfate
Function

Suspected

to

be

unknown.
similar

to

thyropin-type cysteine proteaseinhibitors (protease inhibition).

Chimps,

Encodes

Rhesus

spanning protein that contains a

Monkey, Cow,

RING-H2 finger. Located in the

Rat, Chicken,
Zebrafish,

Ring

finger

protein 139

endoplasmic

multi-membrane

reticulum.

Has

ubiquitin ligase activity. Possibly

Frog, Fruit fly,

responsible for degradation of

Mosquito

tumor suppressor gene.
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,

Hemolytic

anemia,
Impaired
synaptic
plasticity, IgA
nephropathy

Encodes the protein core of

chains.

Hypertension

Lung cancer,
pancreatic
cancer,
variation

of

age

at

menarche.
Hereditary
renal
nonmedullary
thyroid
cancer

and

Chimps,
Rhesus
Monkey, Cow,
Chicken,
Zebrafish,
Frog, Fruit fly,
17

13

TATDN1

Mosquito,

A.

thaliana, Rice,
S. cerevisiae,
K.

lactis,

TatD

Dnase

domain

Function unknown.

NA

containing 1

E.

gossypii,

S.

pombe,

M.

oryzae,

N.

crassa
Precancerou
s
Chimps,
Rhesus

18

14

EEF1A1

hepatic

lesions

in

Encodes an isoform of the alpha

hepatitis

B

Monkey, Cow,

Eukaryotic

subunit of the elongation factor-1

related

Rat, Chicken,

translation

complex

enzymatically

carcinogenes

Zebrafish,

elongation

delivers amino-acyl tRNAs to the

is. Also other

factor 1 alpha

ribosome

diseases

1

Expressed in the brain, placenta,

associated

lung, liver, kidney, and pancreas

with telomere

Frog,

A.

thaliana, Fruit
fly

and

that
during

translation.

Mosquito

liver

dysfunction,
and/or

DNA

damage.
Cancers

breast, liver,

Chimps,
Rhesus
19

14

AGR2

-

Part of the pro-oncogenic protein

Monkey, Cow,

Anterior

disulfide isomerase (PDI) family -

Rat, Chicken,

gradient 2

it maintains homeostasis in the

Zebrafish,

endoplasmic reticulum

Frog

throat, colon,
pancreatic,
ovarian,
thyroid,
gastric,
prostrate,
adenoma etc.
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Chimps,

DnaJ

Rhesus
20

14

Monkey, Cow,

DNAJA1

Rat, Chicken,
Zebrafish,

homolog
superfamily A
member

Pancreatic

DnaJ heat shock superfamily

cancer

1

isoform

Frog
Chimps,
Rhesus
21

14

Monkey, Cow,

TMEM168

Rat, Chicken,
Zebrafish,

Transmembra

Proposed: membrane-associated

ne

HD

protein

168

superfamily

NA

phosphohydrolase

Frog
Encodes member of M14 family
of

Peripheral

Chimps,
Rhesus
Monkey, Cow,
22

15

CPE

Rat, Chicken,
Zebrafish,
Frog,

Metallo-carboxypeptidases.
membrane

protein

Type
diabetes

cleaves C-terminal amino acid

Pancreatic

residues

cancer

&

is

involved

in

Carboxy-

biosynthesis of peptide hormones

Colorectal

peptidase E

& neurotransmitters like insulin.

cancer

Functions

Alzheimer's,

C.

factor

elegans.

as

a

neurotrophic

promoting

neuronal

2

Coronary

survival and/or sorting receptor

atheroscleros

that binds to regulated secretory

is Obesity

pathway proteins.
Breast
cancer,
Chimps,
Rhesus
23

17

GREB1
KIAA0575

or

Monkey, Cow,
Rat, Chicken,
Zebrafish,
Frog

An

Growth
regulation by
estrogen

in

breast cancer
1

early

response

estrogen-

Ovarian

responsive gene in the estrogen

cancer,

receptor-regulated

Endometriosi

pathway.

Believed to play an important role

s,

in

cancer,

hormone-responsive

and cancer.

tissues

Prostrate

Polycystic
ovarian
syndrome

89

Crohn's
disease,
Chimps,

24

20

BSN

or

ZNF231

Expressed primarily in the brain,

Rhesus

Bassoon

Monkey, Cow,

presynaptic

Rat, Chicken,

cytomatrix

Zebrafish,

protein

this gene is believed to encode a
scaffolding protein that is involved
in

organizing

the

presynaptic

cytoskeleton (metal ion binding).

Frog

Schizophreni
a,
neurodegene
rative
disorders like
multiple
system
atrophy.

In humans, this gene is upstream

Chimps,

25

20

ABHD8

Rhesus

Abhydrolase

Monkey, Cow,

domain-

Rat, Chicken,

containing

Zebrafish,

protein 8

of,

and

in

head-to-head

orientation with the gene for
mitochondrial ribosomal protein
L34.

Predicted

protein

has

secretory lipase domains.
Encodes a member of the folate
receptor family. Proteins of this

26

21

FOLR2
FBP

or

Rhesus
Monkey, Cow,
Rat

family
Folate
receptor

have

high

sequence

homology with each other, and
2

(fetal)

have a high affinity for folic acid
and its derivatives, mediating the
delivery

of

methyltetrahydrofolate

5to

the

interior of cells.

that is required for organizing the

Rhesus
25

PALLD

Monkey, Cow,
Rat, Chicken,

actin cytoskeleton - a component
Palladin

of actin containing microfilaments
that is involved in the control of

Zebrafish,

cell

Frog

shape,

contraction.

90

Rheumatoid
arthritis,
atheroscleros
is,
osteoarthritis,
pancreatic
cancer,
arsenic
susceptibility
in mice.

Encodes a cytoskeletal protein

Chimps,

27

cancer

alpha/beta hydrolase fold and

Frog

Chimps,

Breast

adhesion

and

Pancreatic
cancer,
breast
cancer, colon
cancer,
atheroscleros
is, myocardial
infarction.

Cardiomyopa
thy,
Encodes a membrane-associated
protein that is part of the ATPbinding
Chimps,

28

27

ABCC9

cassette

(transport

superfamily

various

molecules

Rhesus

ATP-binding

across extra- and intra-cellular

Monkey, Cow,

cassette,

membranes). This protein is also

Rat, Chicken,

subfamily

Zebrafish,

(CFTR/MRP),

is

Frog, Fruit fly,

member 9

resistance. The protein forms

C

Mosquito

a part of the MRP subfamily that
involved

in

multi-drug

ATP-sensitive

potassium

channels in cardiac, skeletal, and
vascular

and

non-vascular

smooth muscle.

aging

pathology,
Alzheimer's,
early
repolarization
syndrome,
Brugada
syndrome,
myocardial
infarction,
hypertrichosi
s,

Cantu

syndrome,
familial
hypokalemic
periodic
paralysis.

Encodes member of R3 subtype
family of receptor-type protein
tyrosine phosphatase. Localized
to apical surface of polarized cells

Protein
29

27

PTPRO

and may have tissue specific

Chimps, Cow,

tyrosine

Rat, Chicken,

phosphatase,

Zebrafish

receptor type,
O

functions through activation of
Src

family

kinases.

Multiple

isoform-specific & tissue-specific
functions (regulation of osteoclast
production & activity, inhibition of
cell proliferation & apoptosis candidate TSG).
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Several types
of

cancer

(leukemia,
colon,

liver,

breast,
esophageal,
lung), chronic
fibrotic

liver

diseases,
autosomal
recessive
nephrotic
syndrome.

SWI/SNFrelated,
Chimps,
Rhesus
Monkey, Cow,
30

32

SMARCAD1

Rat, Chicken,
Zebrafish,
Frog, Fruit fly,
Mosquito

matrix-

Encodes a member of the SNF

associated

subfamily of helicase proteins

actin-

that

dependent

restoration

regulator

of

chromatin,
subfamily

plays

a

critical

role

in

of

heterochromatin

organization and propagation of

Adermatoglyphia

epigenetic patterns after DNA
a,

containing

replication by mediating histone
H3/H4 de-acetylation.

DEAD/H box
1
Chimps,
31

34

ZBBX

Rhesus
Monkey, Cow,
Rat, Frog

Zinc finger, Bbox

domain

Function unknown.

NA

containing
Structurally similar to a related
gene

on

Encodes

Y
a

chromosome.

member

of

the

krueppel C2H2-type zinc-finger
protein family. Full-length protein
Chimps, Cow,
32

X

ZFX

Rat, Chicken,
Zebrafish,
Frog

Zinc

finger

protein,

X-

linked

product

contains

an

acidic

transcriptional activation domain,
a nuclear localization sequence &
DNA binding domain (13 C2H2type zinc fingers). Mice studies
suggest role in stem cell selfrenewal,

not

differentiation

of

growth

&

stem

cell

progeny.

33

X

USP9X

Chimps, Cow,

Ubiquitin

Rat, Chicken,

specific

Zebrafish,

peptidase

Frog

X-linked

Encodes

9,

a

of

of cancer squamous
cell,
colorectal,
liver,
leukemia,
gastric,
glioma),
acute
myeloid
leukemia
(mice).

the

peptidase C19 family that is

Cancers,

similar

ubiquitin-specific

Turner's

Escapes

syndrome

to

proteases.
inactivation.
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member

Several types

X-

Table IV.8. Human LSS candidate genes and their location in the canine genome
Candidate

Homo

sapiens Canis

familiaris

Musculo-skeletal

Chromosome

Chromosome

Number

Number

COL1A1

17

CF 9

LSS

COL1A2

7

CF 14

LSS, OI, EDS

COL2A1

12

CF 27

OA, LSS

COL9A1

6

CF 12

OA, LSS

COL9A2*

1

CF 15

OA, LSS, DDD

COL9A3

20

CF 24

OA, LSS, DDD

COL11A1

1

CF 6

OA, LSS

COL11A2*

6

CF 12

OA, LSS, DDD, OPLL

VDR

12

CF 5

DDD, LSS

MMP-3

11

CF 27

DDD, LSS

Genes

diseases associated

* Strong association found in human lumbar spinal stenosis studies.
Legend
COL (x) A (y): Collagen Type (x), Alpha (y)

CF:

Canis

familiaris

chromosome

number
VDR: Vitamin D Receptor

MMP-3: Matrix Metallopeptidase 3

OA: Osteoarthritis

DDD: Degenerative Disc Disease

EDS: Ehlers-Danlos syndrome

OI: Osteogenesis imperfecta

OPLL: Ossification of Posterior Longitudinal LSS: Lumbar Spinal Stenosis
Ligament
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CHAPTER V. OVERALL SUMMARY AND CONCLUSIONS

Lumbosacral stenosis (LS) in large breed dogs is a major debilitating condition that can
often lead to compression, irritation and stretching injury of nerves and their blood vessels
that can then lead to clinical conditions.

The most common outward signs of LS on

physical examination in dogs include a painful reaction to palpation of the lower back region
or elevation of the tail, abnormal tail carriage, reluctance to sit, reluctance to jump up into
a car or truck, refusal to climb stairs or other obstacles, and reluctance to assume
positions that require hyperextension of the lower back such as standing upright on the
hind limbs or jumping over obstacles 16. Working dogs differ from most companion dogs in
that they are bred and trained to be stoic and are highly motivated to do their job. They
often mask clinical signs of pain in the early stages. Thus, LS in working dogs, especially
in high-drive breeds like Labrador retrievers, often does not become apparent until the
dog develops an irreversible functional deficit. By the time this happens, the likelihood of
return to full active duty is significantly decreased. Early detection of the likelihood of this
disease occurring and implementation of necessary rehabilitative treatments is critical for
minimizing loss of man-hours, financial investment, and mission readiness for teams that
depend on working dogs. The current standard for detection of LS usually involves
expensive radiological imaging investigations like computed tomography (CT) and
magnetic resonance imaging (MRI). These methods are expensive and lengthy, not really
feasible at the time of procurement of dogs for training intention. Basic radiographs are
used instead that can rule out musculoskeletal diseases like canine hip dysplasia and
canine elbow dysplasia, but cannot detect lumbosacral joint abnormalities like LS. This
warrants the development of a possible genetic biomarker for the disease that can
potentially inexpensively help identify the predisposition of LS well before symptoms
become too severe. The goal is to identify the structural risk factor before the dog starts
showing irreversible clinical signs and is forced to retire – so early intervention would
allow for implementations of modified training protocols or re-designed working tasks
aiming for minimizing loss of muscle mass and developing of compensatory gait
abnormalities by affected dogs. An improved understanding of genetic risk factors would
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also assist international working dog breeder associations in their efforts to produce
higher quality dogs.
At the time of inception for this project and on its completion, no published information
could be found describing the genetic risk factors for LS in the Labrador retrievers.
Studies have stated that Labrador retrievers are at high-risk for LS, but the exact reasons
are mostly unknown lacking scientific evidence. The purpose of this project was to
phenotype and genotype LS in Labrador retrievers. In this project, we focused on young
working Labrador retrievers to detect genetic predisposition without the interferance of
aging as a co-factor. We also selected MWD housed at the same base to rule out other
environmental variables.
The most significant finding from the first study of this project was the development of the
novel CT measurement of fat area ratio (FAR) to phenotypically quantify LS allowing
robust statistical analyses to strengthen research findings (Chapter III). This FAR
measurement displayed a strong association with the qualitative assessment of LS (as
made by a veterinary radiologist, the current standard). The other measurement i.e. canal
area ratio or CAR was not so successful in agreement with CT qualitative diagnosis of LS.
Possible reason for this observation could be due to the fact that just a subjectively
“narrow” canal (as estimated by the ratio of the canal area over vertebral body area)
would not be assigned by the radiologist as LS positive without the presence of other
characteristic signs of LS – loss of epidural fat being one such trait. Since FAR is a
measure of this loss of epidural fat in the vertebral canal, this could be the reason behind
FAR having good agreement with qualitative assessment of LS as made by a licensed
veterinary radiologist. Because the genotyping study (Chapter IV) was a prospective
study, the study design allowed for CT scans to include images of 8 vertebral locations
that included both part of the lumbar spinal canal (L4) as well as the “standard”
lumbosacral spine (L5 – S1) recorded in the clinical setting. The two additional location
FAR values were also included in the selection process for dogs whose exomes were to
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be sequenced, even though the measurements at these two locations could not be
validated in study 1 (chapter III).
Another significant finding from this project came from the second study. We were able to
identify 3 new possible “candidate genes” – TTR, FOLR2 and USP9X. Even though there
are no genetic studies that can explain whether these 3 genes are true candidate genes,
few non-genetic studies have hinted at possible associations. Transthyretin (TTR) has
been associated with Senile Systemic Amyloidosis or SSA – a condition often appearing
simultaneously with LSS in humans. Folate receptor 2 or FOLR2 has also been found in
macrophages in the synovial lining of individuals affected by osteoarthritis – a condition
also found to be present in individuals already affected by LSS. And lastly, Ubiquitin
Specific Peptidase 9 X-linked or USP9X has differential expression between males and
females, and the difference in incidence rate of LS in males and females could have a
connection with the expression patterns of this gene. The connection of LS with these
genes is spurious at best at the present time; so more rigorous investigations are
necessary where robust statistical analyses can be done before any claims of association
can be made. The other 30 genes also identified as carrying exonic variants differing
between LS positive and LS negative groups could also have significance, even though
none could be found in the present date (limited by the annotations of genes uploaded by
different research groups working on different subjects). The study also looked at human
LSS candidate genes, however no significant variants were detected. However, it is too
early to rule out these candidate genes, further investigations are needed to either
confirm their validity as canine LS candidate genes before any claims can be made that
canine LS and human LSS do not share the same disease pathology i.e. same candidate
genes.
This was an exploratory study of LS in a pre-disposed and high-risk breed

130

. However

most studies of LS in dogs lean heavily towards German shepherds (the most commonly
affected breed according to studies reported), more studies are required investigating LS
in Labrador retrievers. Further investigations of these genes and the role they might play
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in LS in other breeds (not just Labrador retrievers) need to be undertaken – that could tell
us if they are breed specific factors or more universal. These findings could also very well
be translated into the human lumbar spinal stenosis problem that closely resembles
canine LS.
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CHAPTER VI. RECOMMENDATIONS
A genetic test for detecting risk factors of LS in working dogs could help reduce the risk
of early retirement in these valued animals.

Lumbosacral stenosis is not detectable

with routine screening methods currently used at the time of military working dog
procurement. A genetic test that could be successfully used at the time of procurement
could potentially save the military millions of dollars. In addition, this genetic test could
help owners, breeders, and trainers of other at-risk working dogs detect the problem
earlier and implement preventative measures. Our study identified promising candidate
genes that warrant further study. In particular, transthyretin (TTR) may be a marker for
premature degeneration of connective and ligamentous tissues. Future studies of blood
and tissue samples from clinically affected dogs would be needed to explore the true
nature of the relationship between TTR and LS. Small sample sizes are not ideal for
genome wide association studies (GWAS), but GWAS can be useful in future
association studies if the sample size could be larger. So a GWAS for LS in a larger
sample of Labrador retrievers could yield interesting results.

Improved methods for quantitative deep phenotyping of LS in dogs could be helpful for
supporting development of these genetic tests. In the current study, fat area ratio (FAR)
was introduced as a novel CT measurement that can quantitatively characterize
lumbosacral stenosis (LS) in Labrador retrievers for research purposes and possibly
also in other breeds of dogs. In order to develop more definitive threshold values,
further studies are needed in a larger sample of Labrador retrievers as well as other atrisk breeds. Further analysis is also needed to compare the ratio measurements with
the absolute measurements in this study. Canal area ratio or CAR did not have a
significant association with qualitative LS in our sample population of dogs, however
further studies testing the relationship between CAR and FAR may be helpful. These
two measures detect different structural phenotypic traits and may also be
complementary. Canal area ratio primarily quantifies bony canal narrowing and FAR
detects narrowing due to a combination of bony and soft tissue encroachment (i.e. the
combination of characteristics most often used by radiologists for diagnosing the
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condition). Consistent with previous studies, low back pain status (LBP) was not
significantly associated with an overall qualitative diagnosis of LS.

However, when

multi-level stenosis (i.e. stenosis at 2 or more vertebral levels) was examined as a
separate factor, subjective evidence of a possible association between multi-level
stenosis and LBP was observed. Statistically significant associations were not detected
due to small sample size. Future studies should explore the interactions among risk of
early retirement due to LS and all possible co-variates such as LBP status, number of
levels of stenosis, age, gender, working status, and body weight.
Improved methods for collecting, storing and analyzing genetic material are also needed
to support development of genetic screening tests for LS in dogs. Multiple studies have
reported several different protocols for extraction of DNA from biological samples
(including blood) on FTA™ cards. After several trials using different commercially
available protocols, the GenTegra platform (combination of GenTegra’s GenSolve kit
and QIAGEN’s blood purification kit) had the best yield of DNA for dogs in our sample –
both quality and quantity of the extracted DNA was sufficient for downstream
sequencing reactions. Thus, use of FTA cards was found to be a feasible method for
collection and storage of blood samples, and extraction of DNA for genetic testing in
military working dogs.

This technique could therefore be used in future studies of

military working dogs deployed in locations far away from medical facilities and/or
sources of refrigeration.
An improved understanding of the progression of LS in dogs is also needed. There are
two distinct etiologies of LS in dogs – congenital and acquired. Degenerative LS falls
into the acquired category, while idiopathic LS is a rare but congenital type of LS. The
primary aim would be to understand the difference between idiopathic and degenerative
LS – whether different genetic mechanisms are responsible for the different types of LS
or whether they share the same/similar pathophysiological mechanisms. One possible
future study could be to follow the outcomes of the same 40 dogs in this study over the
years to see if any of the previously LS negative dogs develop clinical signs or become
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LS positive over time and/or whether the LS positive dogs develop worsening of their
condition and/or experience early retirement. A longitudinal study starting with a large
number of young Labrador retrievers and tracking their growth, as well as the
occurrence and/or progression of LS in them over the years could also be informative
for our attempt at understanding the mechanisms underlying LS in dogs. This study
design will also allow for identifying and understanding the distinction between
idiopathic LS and degenerative LS. This type of study design would also allow for
studying the relationship between working tasks performed by the dogs and the effect
they might have on the lumbosacral spine of the dogs.
More studies also need to be done to develop more sensitive tests for early detection
and more accurate localization of lower back pain in working dogs. Current standard
clinical tests such as palpation of low back region of the spine and recording the dog’s
reaction to the stimuli are too insensitive for early detection of LS in stoic, high-drive
working dogs. Breed specific phenotypic traits involving the lumbosacral and the
sacroiliac joints also warrant further investigations as possible sources of LBP and early
retirement in working dogs, i.e. the dog could be displaying signs of pain due to these
other conditions and not LS.
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Appendix I: Protocol used for DNA extraction from FTA cards

GenTegra™ GenSolve™ DNA recovery Kit (GenTegra LLC., Pleasanton,
CA)
Kit Contents
1. Recovery Solution A; 0.2 ml, 4 each
2. 1% LiDS Solution; 66 ml, 1 bottle
3. Protease solution; 2.5 ml, 1 vial
4. Recovery Solution B; 2.5 ml, 1 vial
5. User Guide
Storage
Protease should be stored at 2-8 °C. All other components can be stored at either room
temperature or 2-8 °C. After re-suspension and addition of Protease, Recovery Solution
A should be used within 2-3 hours for maximum DNA yield.
Additional Equipment and Materials required
o Incubator/Shaker
o GenTegra Spin Basket/Tube Assembly (GenTegra #GVSPIN250)
o Ethanol, 100%
o QIAGEN QIAamp DNA Blood Mini Kit (50 preps, QIAGEN #51104)
o QIAGEN 2.0 ml collection tubes (QIAGEN #19201)
o Millipore Microcon MRCF0R100 (optional)
o Microfuge Tubes, 1.7 ml and 2.0 ml
o P200 and P1000 pipettes, pipette tips
o Microcentrifuge
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Kit Protocol
Stage	
  1:	
  DNA	
  recovery	
  
1. Pre-heat Incubator/Shaker to 65°C.
2. To the bottle of Solution A, add 1% LiDS according to the volumes in Table 1.
Table 1. Volume of 1% LiDS and Protease used to add to Solution A
Volume of 1% LiDS

Volume of Protease

16 ml

535 µL

3. Vortex briefly to mix Solution A bottle and LiDS solution.
4. Add Protease into the vial of Solution A from Step 2 according to the volumes
described in Table 1 and vortex briefly.
5. Punch element(s) into one 2 ml microtube for each unique sample.
6. Add 620 µL of Recovery Solution A/Protease mix.
7. Place the tube in the Incubator/Shaker pre-heated to 65 °C. Vortex ~1 minute at
1,400 rpm and inspect to make sure that each element is completely submerged
in the solution; repeat until all elements are submerged. Continue vortexing for
one hour. It is important to vortex at 1,400 rpm for maximum DNA recovery. If
speed <1,400 rpm, vortex for 2 hours, speed < 700 rpm is not recommended.
8. Centrifuge at 16,300 x g for 0.5 minutes to collect liquid off cap.
9. Add 20 µL of Recovery Solution B to a new microcentrifuge tube and insert a
spin basket. Transfer the solution from step 7 into the Spin Basket making sure
to transfer along the element(s) by scooping it with pipette tip.
10. Centrifuge at 16,300 x g for two minutes.
11. Discard Spin Basket and element.
12. Pulse vortex each microtube.
13. Proceed directly to DNA purification.
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Stage	
  2:	
  DNA	
  Purification	
  
1. Add 600 µL of 100% Ethanol to each microtube containing recovered DNA.
2. Pulse-vortex each sample. Centrifuge briefly.
3. Load 600 µL of the sample onto a spin column/collection tube. Close the cap and
centrifuge at 6,000 x g for 1 minute. Place the spin column in a new 2 ml
collection tube and discard the tube containing the filtrate.
4. Repeat step 3 until the entire sample has been applied into the spin column.
5. Add 500 µL of AW1 Buffer onto the spin column and centrifuge at 6,000 x g for 1
minute. Discard the collection tube containing the filtrate and place the spin
column in a new 2 ml collection tube.
6. Add 500 µL of AW2 Buffer onto the spin column and centrifuge at 16,300 x g for
4 minutes. Discard the collection tube containing the filtrate and place the spin
column in a new 2 ml collection tube.
7. Centrifuge at 16,300 x g for 1.5 minutes.
8. Place the spin column in a new 1.7 ml tube.
9. Elute the DNA sample by adding 200 µL of AE Buffer to spin column. Incubate
the sample at room temperature for 5 minutes and centrifuge at 6000 x g for 1
minute.
10. Elute is ready for quantitation and downstream analysis.
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Appendix II: Description of an unexpected qualitative phenotypic trait observed
in this sample of Labrador retrievers, i.e. “a reverse trapezoid vertebral canal”.
Previous studies have reported that the shape of the lumbosacral canal becomes
progressively semi-circular or crescent shaped as it transitions from the cranial to the
caudal end of the canal 112, with the cross-sectional area of the canal is at its greatest at
mid-lumbar level and gets progressively narrower both cranially and caudally to that.
Conventional belief is that the canal begins wider at the lumbar level and then
progressively narrows as the canal transitions to the sacrum.
However, during the construction of bar-graphs to represent mean canal area ratio
(CAR) and mean fat area ratio (FAR) values of LS negative and LS positive dogs at
each of the 6 vertebral locations (L5Cd – S1Cr) in chapter III, an interesting observation
was made with regards to the shape and size of the vertebral canal as it transitions from
the cranial end to the caudal end of the body. At each vertebral level, the cranial end
was narrower than the caudal end. This “reverse trapezoid” pattern of the vertebral
canal was not found to be reported in any previously published literature.
This structural characteristic of the lumbosacral spine was observed in all dogs in both
the studies (1 and 2) of this project for both the ratio measurements: mean canal area
ratio or CAR (Figure A.1 and A.2); and mean fat area ratio or FAR (Figure A.3 and A.4).
Since vertebral body measurements were used to construct the ratios, the analyses
were also repeated with the absolute values to test whether the vertebral body
dimensions could be a source of variation. However, this trend was observed in both
sets of absolute values – mean canal area or CA (Figure A.5 and A.6); and mean fat
area or FA (Figure A.7 and A.8).
This trait appears to be more prominent from L5 cranial to S1 cranial locations. It is
important to note that all dogs in our project were of a single breed i.e. Labrador
retrievers. So this trait could be specific to this breed alone, or it could be a canine
morphological trait in general. The number of dogs in both studies was too small to
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assign this trait to this specific breed. Further studies are needed in larger sample of
Labrador retrievers (to validate this observation) as well as other breeds of dogs to
characterize this phenotype as either breed specific or non-breed specific.
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Figure	
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Figure A.1. Mean canal area ratios (CARs) in study 1
(N=24 at L5Cd – L6Cr; N=25 at L6Cd – S1Cr)
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Figure	
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Figure A.2. Mean canal area ratios (CARs) in study 2
(N=40 at L4Cd – S1Cr)
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Figure	
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Figure A.3. Mean fat area ratios (FARs) in study 1
(N=24 at L5Cd – L6Cr; N=25 at L6Cd – S1Cr)
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Figure	
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Figure A.4. Mean fat area ratios (FARs) in study 2
(N=40 at L4Cd – S1Cr)
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Figure	
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Figure A.5. Mean canal areas (CAs) in study 1
(N=24 at L5Cd – L6Cr; N=25 at L6Cd – S1Cr)

	
  

132

S1Cr	
  

Figure	
  A.6.	
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Figure A.6. Mean canal areas (CAs) in study 2
(N=40 at L4Cd – S1Cr)
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Figure	
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Figure A.7. Mean fat areas (FAs) in study 1
(N=24 at L5Cd – L6Cr; N=25 at L6Cd – S1Cr)
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Figure	
  A.8.	
  

Mean FA
0.800	
  

0.731	
  

0.696	
  

0.700	
  
0.600	
  

0.515	
  

0.500	
  

0.464	
  

0.415	
  

0.446	
  

0.400	
  
0.300	
  

0.246	
  

0.257	
  

L4Cd	
  

L5Cr	
  

0.200	
  
0.100	
  
0.000	
  
L5Cd	
  

L6Cr	
  

L6Cd	
  

L7Cr	
  

L7Cd	
  

Figure A.8. Mean fat areas (FAs) in study 2
(N=40 at L4Cd – S1Cr)
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Appendix III: Logistic regression analysis of the association between FAR and
qualitative LS status in the 40 dogs recruited for the second study (chapter IV)
Logistic regression analysis from study 1 was repeated in 40 dogs of the second study
(see chapter III). The association between fat area ratio (FAR) values and the
qualitative assessment of LS was statistically significant (p<0.0001) at only one
vertebral location – L6 cranial (Figure A.9). We were able to identify that age is a
covariant in this model, i.e. FAR values have better correspondence with qualitative LS
status with increasing age (Figure A.10). Study 1 was able to identify that older dogs
have a higher incidence of qualitative LS. However it is important to note that older dogs
are at a higher risk of acquiring degenerative LS, a disease process that could be
separate from idiopathic LS (type of LS probably observed in study 2 sample of young
Labrador retrievers). This warrants further analysis where distinction between idiopathic
LS and degenerative LS is possible.
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Figure A.9. Logistic regression of FAR v qualitative LS at L6Cr
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Figure	
  A.10.	
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Figure A.10. Logistic regression of age v qualitative LS at L6Cr

	
  

	
  

138

Appendix IV: Proposed explanations for clinical low back pain observed in dogs
from both studies.
In study 1, there were 14 LS positive dogs. Eight of these 14 dogs were low back pain
(LBP) negative. The remaining 6 dogs were positive for both LS and LBP. Five out of
these 6 dogs (83.33%) were stenotic at more than one vertebral level, while the
remaining 1 dog was LS positive at only one vertebral location. There were 3 (out of 11)
dogs that were LBP positive despite being LS negative. This contradiction can be
explained by the presence of one or more of the following conditions that can cause
LBP in the lumbosacral junction (besides LS) in all 3 dogs: sacroiliac joint disease 132,
foraminal stenosis 133, and Schmorl’s nodes 134.
In study 2 there were 33 LS positive dogs. Fifteen out of these 33 were LBP negative
(possible causes explained in previous chapters). The remaining 18 were positive for
both LS and LBP. Fourteen of these 18 dogs (77.78%) were stenotic at more than one
vertebral level, while the remaining 4 were LS positive at only a single location. There
were 6 (out of 7) dogs that were LBP positive despite being LS negative. Again the
reason for this discrepancy could be due to other clinical conditions that can affect the
lumbosacral spine of large breed dogs.
Out of the 8 dogs selected for exome sequencing, the LS positive group comprised of 2
LBP positive dogs and 2 LBP negative dogs. It is interesting to note that the 2 LBP
negative LS positive dogs had stenosis at only 1 vertebral level, while each of the 2 LBP
positive LS positive dogs were stenotic at more than 2 levels (3 and 4 levels). On the
other hand the LS negative group had only 1 dog that was negative for both LS and
LBP. The other 3 dogs showed signs of pain, though only one of them had stenosis at a
single level. The pain displayed by these relatively asymptomatic dogs could be due to
other reasons (previously described) besides LS.
So in both studies, majority (83% in study 1, and 78% in study 2) of the LS positive dogs
that were also LBP positive, were stenotic at more than one vertebral level. This
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observation could be explained by the theory that compression of the cauda equina
nerves at 2 or more locations causes increased disruption of electrical signals and
arterial blood supply 65 62. Future studies are necessary to understand the true nature of
the relationship between LS and LBP, especially the significance of LS at multiple
vertebral levels on presence or absence of LBP.
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Appendix V: Analysis of covariance and multivariate logistic regression tests for
effects of covariates on comparisons between FAR and LS status in dogs from
both studies.
Analyses of covariance (ANCOVA) were done using PROC GLM procedure of statistical
software SAS on combined datasets of studies 1 and 2 (N = 65). The ANCOVA tested
whether regression of the quantitative measurement FAR on age (covariate) differed
between the two groups (LS positive and LS negative) at the 6 common vertebral
locations: L5Cd, L6Cr, L6Cd, L7Cr, L7Cd and S1Cr. The terms in the model are: main
effect of group, main effect of age and the interaction of the group and age. The
significant interaction of age and group in the ANCOVA would be an indicator of the
different slopes between the two groups (LS positive and LS negative). The p-values for
ANCOVA analyses on the combined dataset were significant for the main effect of
group (qualitative diagnosis of LS) at all locations except L5Cd: L6Cr (p<0.0001), L6Cd
(p=0.0097), L7Cr (p=0.0010), L7Cd (p<0.0001) and S1Cr (p<0.0001). This also serves
as a verification of earlier results of study 1 and L6Cr results in study 2. The p-value
was also significant for the main effect of age at L7Cr (p=0.0058). However, the
interaction term (age and qualitative LS) was not significant at any of the 6 locations.
In addition the multivariate logistic regression was done on this combined dataset,
where variables such as age, weight, and sex were added besides the LS diagnosis to
see if any of them or their interactions can predict FAR. The p-values were significant
for the main effect of LS at 4 of the 6 vertebral locations: L5Cd (p=0.0189), L6 Cr
(p<0.0001), L7Cr (p=0.0018) and S1Cr (p=0.0033). Interaction of age with LS status
and age was not significant at any of the 6 locations. in agreement with previous
findings)
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